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ABSTRACT 
 
Characterization of the Tri10 gene from Fusarium sporotrichioides.  (May 2003) 
Andrew George Tag, B.S., Southeast Missouri State University; 
M.S. Southeast Missouri State University 
Chair of Advisory Committee:  Dr. Marian N. Beremand 
 The trichothecene mycotoxins are secondary metabolites produced by a 
variety of fungal genera including Fusarium, Myrothecium, Trichothecium, and 
Stachybotyris, that are toxic to humans and animals that ingest them by 
consumption of contaminated grain.  This work details the characterization of a 
novel regulatory gene from Fusarium sporotrichioides, Tri10, which is located in 
the trichothecene gene cluster.  Northern analysis of Tri10 deletion strains, Tri10 
overexpressing strains, and a Tri6 deletion strain indicated that Tri10 is required 
for wild-type trichothecene gene expression and for wild-type expression of a 
primary metabolic gene, Fpps.  Analysis of these mutants also provided 
evidence for a regulatory feedback loop where Tri10 is required for the 
expression of Tri6 and Tri6 negatively regulates Tri10.  Furthermore, under 
certain growth conditions the sensitivity of ∆Tri10 and ∆Tri6 strains to T-2 toxin 
was increased.  Analysis of mutants altered in the expression and genomic 
position of Tri10 revealed that placing Tri10 under the control of an exogenous 
promoter resulted in the overexpression of Tri10 and the other Tri genes 
whether this construct was located inside or outside of the Tri gene cluster.   
 iv
 
Work outside of this study has shown that in addition to Fpps, three other 
primary metabolic genes from the isoprenoid pathway feeding into trichothecene 
biosynthesis (Acat, Mk, Hmgs) are also influenced by the expression of Tri10 
and Tri6.  In the present study, targeted cDNA microarrays were used in 
conjunction with multiple mutants to reveal a large group of genes, containing 
both trichothecene and primary metabolic genes, which were positively 
influenced by Tri10 expression.  At the same time, a small group of genes 
negatively influenced by Tri10 expression was observed.  These results were in 
agreement with observations made outside of this study and validated the use of 
targeted cDNA microarrays for further studies.   
 
Additional analysis of the regulatory network linking trichothecene 
secondary metabolism and isoprenoid primary metabolism revealed that in a 
mutant blocked in the first step of the pathway, and therefore in the absence of 
trichothecene production, this regulatory link is mediated by Tri10 and Tri6. 
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CHAPTER I 
 
 
INTRODUCTION 
 
Secondary metabolites are compounds produced by organisms which 
appear, at least on the surface, to not be necessary for the survival of the 
organism in the laboratory.  However, upon closer investigation it has been 
revealed that many secondary metabolites do have a function in the well-being 
of the organism and may in fact increase the fitness of the organism in its natural 
environment (37).  One such activity may be the production of antibiotics or 
toxins which keep the competition at bay or facilitate infection of a host.  
Mycotoxins are fungal secondary metabolites which may benefit the fungus in 
these ways, but were first recognized because they are harmful to humans and 
animals.  Of the great number of mycotoxins being studied, one of the most 
important groups is the trichothecenes. 
 
Trichothecenes were among the first mycotoxins scientifically 
documented to be important in human and animal health.  In the early 1900’s, a 
disease known as alimentary toxic aleukia (ATA) was widely reported in Siberia 
which was characterized by a hemorrhagic skin rash, bleeding from the nose, 
throat and gums, and leucopenia as a result of destruction of the bone marrow.  
_____________________  
This dissertation follows the style and format of Applied and Environmental 
Microbiology. 
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In the following years, the disease reappeared sporadically in other 
republics of the former Soviet Union until in the early 1940’s when a more 
widespread outbreak of ATA occurred (62).  This outbreak coincided with a 
deteriorating food supply due to World War II and much of the peasant 
population was forced to harvest grain which had overwintered in the fields 
covered with snow.  At its worst, between 1942 and 1944, it is estimated that the 
mortality rate approached 60 percent in certain counties and the number of 
deaths reached into the hundreds of thousands (62, 69). 
 
The health effects observed in both humans and animals that consumed 
the overwintered cereal grains spurred a tremendous effort to both identify the 
offending agent and determine its mode of action.  Initially it was thought that 
ATA was due to an infectious epidemic or vitamin deficiency, however, as 
described below it was eventually determined that the probable cause was due 
to the consumption of trichothecenes which contaminated overwintered cereal 
grains (62).   
 
 In 1948, Freeman and Morrison isolated a toxic compound from 
Trichothecium roseum and named it trichothecin, the first trichothecene (39).  
Since then, over 180 different trichothecenes have been identified (43).  
Trichothecenes are produced by several genera of filamentous fungi including 
Fusarium, Stachybotrys, Myrothecium, and Trichothecium (8, 34, 39, 104).  The 
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trichothecenes are tricyclic sesquiterpenoids which possess an epoxide at 
carbons 12 and 13, and a double bond between carbons 9 and 10 (Fig. 1-1).  
Type A trichothecenes, which include T-2 toxin and 4, 15-diacetoxyscirpenol 
(DAS) are defined by the presence of hydrogen, hydroxyl, or acetoxyl at carbons 
3, 4, 7, 8, and 15.  Type B trichothecenes such as deoxynivalenol (DON) 
possess a carbonyl group at carbon 8 (Fig. 1-1).  Lastly, the macrocyclic 
trichothecenes are di- and tricyclic esters.   
 
In 1973, Mirocha and Pathre provided evidence implicating T-2 toxin was 
the probable causal agent of ATA (80).  They compared a toxic crude 
preparation from a Russian ATA outbreak with a T-2 toxin standard by gas 
chromatography-mass spectrometry, thin-layer chromatography, and infrared 
spectrometry.  Their data suggested that T-2 toxin was more likely the causal 
agent of ATA than the steroid compounds sporofusarin and poaefusarin which 
had been previously reported by Olifson (reviewed by (9)).  In a crude 
preparation provided by Olifson, Mirocha and Pathre found that there were no 
steroid compounds present in the sample but enough T-2 toxin to explain the 
toxicity found in the rat and rabbit skin tests for the toxic activity (80, 95). 
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  The mode of action of the trichothecenes has been studied and has, at 
present, been suggested to function on at least 4 levels in causing disease in 
animals.  In 1968, Ueno, et al. determined that the trichothecenes are extremely 
effective inhibitors of eukaryotic protein synthesis.  As a group, the 
trichothecenes inhibit eukaryotic protein synthesis by binding to the ribosome 
(106).  However, they can be divided into two groups based on the step of 
translation that they inhibit.  It was suggested by Wei and McLaughlin that 
compounds with substitutions only at the R2 group (R2=OH) inhibit elongation or 
termination whereas substitutions at R1 and R3 (R1, R3=OH) promote inhibition 
of initiation (76, 106, 107) (Fig 1-1).  In 1980, Carter, et al showed that two 
similar trichothecenes, trichodermin and fusarenon-X, inhibit eukaryotic protein 
synthesis by blocking the peptidyl transferase step (19). 
 
Although trichothecenes are recognized foremost as protein synthesis 
inhibitors, they also induce apoptosis.  The trichothecene T-2 toxin has been 
shown to induce apoptosis in the thymus (58, 59), spleen, and liver tissue (57) of 
mice.  Other trichothecenes, including the macrocyclic trichothecenes satratoxin 
G, roridin A, and verrucarin A also induce apoptosis to varying degrees, with the 
macrocyclic trichothecenes being the most potent inducers of apoptosis (83, 
111).  This second mode of toxicity appears to be related to the degree to which 
caspase-3 is induced by the binding of the trichothecene to the ribosome and is 
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not directly related to the degree with which a given trichothecene inhibits 
protein synthesis (83, 93). 
The trichothecenes are also immunosuppressive, most likely due to their 
properties as protein synthesis inhibitors and apoptotic agents as discussed 
above.  However, the macrocyclic trichothecenes are also able to stimulate the 
immune system by increasing the production of cytokines at low concentrations 
of toxin and suppress the immune system at high concentrations of toxin (14).  
Lastly, there is some evidence from studies performed on rats that T-2 toxin and 
deoxynivalenol (DON) may function as neurotoxins by disruption of the blood-
brain barrier (105). 
 
Trichothecene production appears to provide an important benefit to the 
producing organism.  All of the fungi reported to produce trichothecenes are 
plant pathogens.  The trichothecenes have been shown to be phytotoxic (16) 
and play a role in virulence in several specific plant-pathogen interactions.  
Several species of Fusarium cause dry rot diseases on a variety of tuber crops 
and this was utilized as a model system in experiments to examine what role, if 
any, the trichothecenes had in the virulence of the pathogen.  Mutant strains of 
both F. sporotrichioides and Gibberella pulicaris (anamorph=Fusarium 
sambucinum) which are unable to produce trichothecenes, exhibit reduced 
virulence on parsnip root (Pastinaca sativa) (27, 31).  However, the ability to 
produce trichothecenes was unnecessary to achieve wild-type levels of virulence 
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on potato with G. pulicaris (27).  In cooler climates, some Fusarium species, 
especially G. zeae (anamorph=F. graminearum), can cause tremendous crop 
losses by causing Gibberella ear rot of maize and wheat head scab.  Although, 
in maize and wheat the trichothecenes are not essential for infection of the host 
plant (7, 45), they do have a role in the virulence of G. zeae in Gibberella ear rot 
of maize and wheat head scab.  Studies using trichothecene non-producing 
mutant strains on maize in the field (45) and on wheat in both the greenhouse 
and the field (7, 23, 30, 85, 86) have clearly demonstrated the trichothecenes as 
virulence factors. 
 
 Once the chemical structures for the first trichothecenes were 
determined, efforts were also initiated to determine their biosynthetic origin and 
biochemical pathways of synthesis.  In 1959, Fishman, et al. first established 
that the trichothecenes are sesquiterpenoid compounds (38).  Hanson and 
Achilladelis subsequently showed that trichothecenes are derived from farnesyl 
pyrophosphate (reviewed in (98)).   
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To date, the most complete information for a trichothecene biosynthetic 
pathway has been obtained from studies on trichothecene production in F. 
sporotrichioides.  The trichothecene biosynthetic pathway has been elucidated in 
F. sporotrichioides NRRL 3299 using a variety of approaches including analysis 
of blocked mutants, isotopic labeling of precursors and cross-feeding 
experiments.  As is true for all trichothecenes, the first step is the cyclization of 
farnesyl pyrophosphate to form trichodiene (36).  The nontoxic compound 
trichodiene is then converted to the highly toxic T-2 toxin through a series of 14 
additional steps involving oxygenation, isomerization, cyclization, esterification, 
and deacetylation (Fig. 1-2).   
 
While the first 9 steps of the trichothecene biosynthetic pathway appear to 
be shared across the Fusaria, the predominant trichothecene end product varies 
from species-to-species and strain-to-strain.  The primary end product in F. 
sporotrichioides NRRL 3299 is T-2 toxin, while in many F. graminearum strains it 
is deoxynivalenol (DON) or nivalenol.  F. sambucinum predominantly produces 
diacetoxyscirpenol (DAS) but some isolates are known to produce T-2 toxin (69). 
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  FIG. 1-2.  Proposed trichothecene biosynthetic pathway for Fusarium 
sporotrichioides NRRL 3299 leading to the production of T-2 toxin. 
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The study of the genetics and molecular biology of trichothecene 
biosynthesis in the Fusaria began in earnest as a multi-pronged approach with 
the parallel development of F. sporotrichioides and F. sambucinum (Gibberella 
pulicaris) as model systems.  A large scale UV mutagenesis and mutant screen 
of F. sporotrichioides was performed using a monoclonal antibody to T-2 toxin to 
look for mutants that no longer made T-2 toxin (10).  This screen identified the 
first four trichothecene genetic loci, Tri1 (formerly Tox1), Tri2 (formerly Tox2), 
Tri3 (formerly Tox3), and Tri4 (formerly Tox4) (10, 74, 75, 84).  These UV-
induced mutants were instrumental in providing the first critical studies that 
definitively established the role of trichothecenes as virulence factors (31), in 
determining the identity and order of many of the intermediates in the T-2 toxin 
biosynthetic pathway (10, 74, 75, 84), and ultimately in the cloning of several Tri 
genes (50, 73).  Of particular interest were strains MB1716 (Tox1-2), which 
accumulates diacetoxyscirpenol (DAS) (10), MB2972 (Tox3-1), which 
accumulates 15-deacetylcalonectrin and 3, 15 dideacetylcalonectrin (84), and 
MB5493 (Tox4-1) which accumulates trichodiene (74).  In all three cases, it was 
possible to feed the strains putative precursors to T-2 toxin which occurred after 
the block in the pathway and have them converted into T-2 toxin.  This provided 
evidence that an accumulated compound was an intermediate in the 
biosynthetic pathway and also indicated that the genes necessary for the steps 
beyond the block were being expressed (75).   
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At the same time, a genetic system was developed in Gibberella pulicaris 
(F. sambucinum) to allow for the mapping of genes by segregation analysis (11, 
24).  Naturally occurring variants in trichothecene production were initially 
analyzed.  These studies revealed that in G. pulicaris the ability to hydroxylate at 
C-8 segregated as a difference at a single gene locus (Tox1) in most crosses 
between C-8+ and C-8- strains.  However, a few C-8- strains, when crossed with 
C-8+ strains, displayed a 3:1 segregation pattern for C-8 hydroxylation (12).  
Thus this step appears to be controlled by at least two separate genes in G. 
pulicaris.  In addition, this study identified at least two loci which affected the 
quantity of trichothecenes produced (12). 
 
In a third approach, reverse genetics was used to clone the first 
trichothecene gene, Tri5 (originally Tox5), from F. sporotrichioides NRRL 3299 
(48).  Tri5 encodes the first enzyme in the trichothecene pathway, trichodiene 
synthase.  Tri5 was isolated from a λgt11 expression library containing genomic 
DNA from F. sporotrichioides using an antibody generated against purified 
trichodiene synthase protein.  Sequence analysis of additional genomic 
fragments recovered from the library provided the sequence of the promoter and 
open reading frame of Tri5 (48).  Tri5 was disrupted by transforming NRRL 3299 
with a vector containing a doubly-truncated fragment of the Tri5 open reading 
frame and a hygromycin resistance cassette.  Transformants possessing a 
disrupted Tri5 gene produced no trichothecenes (49).  Furthermore, the feeding 
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of intermediates beyond trichodiene indicated that the enzymes beyond 
trichodiene synthase were present and active in the Tri5 transformants as shown 
by the conversion of these precursors to T-2 toxin (48, 49).  Tri5 was 
subsequently cloned and disrupted in G. pulicaris and shown to be required for 
trichothecene production in this fungus (49). 
 
Tri3 and Tri4 were found to be linked to Tri5 in F. sporotrichioides shortly 
after a cosmid library was constructed from wild type F. sporotrichioides NRRL 
3299 genomic DNA and probed with a Tri5 gene fragment to isolate cosmids 
harboring Tri5 and contiguous sequences.  When two of these cosmids were 
used in an attempt to complement the trichothecene mutant strains MB5493 
(tri4, formerly Tox4-1-), MB2972 (tri3, formerly Tox3-1-), and MB1716 (tri1-1, 
formerly Tox1-1-) (28, 51, 54), both cosmids complemented the tri4 and tri3 
strains, but neither one complemented the tri1 strain.  This provided the first 
evidence that at least three trichothecene genes were closely linked in a gene 
cluster in F. sporotrichioides (54).  Subsequent analysis of the DNA sequence 
surrounding Tri5 revealed additional Tri genes (Fig. 1-3).  Most of the other 
known core cluster trichothecene genes have been identified and characterized 
in a uniform fashion by DNA sequencing, transformation-mediated gene 
disruption and chemical analysis.   
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The F. sporotrichioides NRRL 3299 trichothecene gene cluster spans at 
least 27 kb and contains 12 identified genes.  Among them are:  2 regulatory 
genes (Tri10 and Tri6) (13, 87), an efflux transporter (Tri12) (1, 4), 7 biosynthetic 
genes (Tri3, Tri4, Tri5, Tri7, Tri8, Tri11, and Tri13) (2, 3, 17, 48, 50, 67, 71, 73), 
and two genes of undetermined function (Tri9 and Tri14) (18, 29) (A. W. Peplow, 
A. G. Tag, G. F. Garifullina, and M. N. Beremand, in press) (Fig. 1-3).  Similar 
gene clusters have been found in Myrothecium and in other Fusarium species 
(17, 102).  Although clustering of genes for secondary metabolism in fungi was 
once thought to be unusual, it is has been found to be more the rule than the 
exception.  In fact, most genes for secondary metabolism in fungi have been 
found to be clustered (63). 
 
In addition to the core trichothecene gene cluster, two genes, Tri101 and 
Tri1 have been isolated from F. sporotrichioides that are positioned elsewhere in 
the genome (65, 66). 
 14
 
 
Tri101 was isolated by two different research groups in screens designed 
to identify potential trichothecene resistance genes by their ability to convey 
trichothecene resistance to yeast cells.  TRI101 was found to acetylate the C-3 
position, converting isotrichodermol to isotrichodermin.  In general, the 
acetylated trichothecenes are less toxic than the corresponding alcohols, thus it 
represented the resistance conveyed to yeast.  However, when Tri101 was 
disrupted in F. sporotrichioides, it did not appear to play an essential role in the 
self-protection of the organism from trichothecenes (72).  The Tri1 gene was 
initially discovered in F. sporotrichioides by isolation of T-2 toxin deficient 
mutants as described above (10), and was recently cloned and characterized 
(78, 79).  The deduced TRI1 sequence indicated that Tri1 encodes a 
cytochrome P450 monooxygenase.  The disruption of Tri1 led to the 
Tri8 Tri7 Tri3 Tri4 Tri6 Tri5 Tri10 Tri9 Tri11 Tri12 Tri13 Tri14
Tri3 = acetyltransferase   Tri9  = unknown 
Tri4 = P450 monooxygenase  Tri10 = regulatory gene 
Tri5 = terpene synthase   Tri11 = P450 monooxygenase 
Tri6 = transcription factor   Tri12 = transporter 
Tri7 = acetyltransferase   Tri13 = P450 monooxygenase 
Tri8 = esterase    Tri14 = unknown 
 
  FIG. 1-3.  The F. sporotrichioides trichothecene gene cluster.  The gene cluster contains 
at least 12 genes and spans approximately 27 kb.  Black bars represent protein coding 
sequence and arrows designate direction of transcription. 
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accumulation of 4, 15-diacetylscirpenol in a similar manner to the UV-induced 
tri1 mutant strain MB1716 and it was shown that the introduction of the Tri1 
gene into the UV mutant strain MB1716 complemented the tri1 mutation (78, 
79).   
 
The genetic regulation of trichothecene production has just begun to be 
understood.  Tri6, a C2-H2 transcription factor located within the core 
trichothecene gene cluster, is required for production of trichothecenes (87).  
Transformants in which the Tri6 gene had been disrupted exhibit a dramatically 
decreased accumulation of the Tri4 and Tri5 transcripts paralleled by the 
prevention of trichothecene biosynthesis and a slight accumulation of trichodiene 
(87).  Further analysis revealed that TRI6 bound specifically to the sequence 5’-
TNAGGCCT-3’ which occurs in the promoter region of all of the known 
trichothecene genes (52).  Similarly, other mycotoxin gene clusters also contain 
pathway-specific regulators.  The aflR and aflJ genes regulate aflatoxin 
production in Aspergillus parasiticus and sterigmatocystin production in A. 
nidulans, and are found within the respective gene clusters for each of these 
organisms. 
 
Like many secondary metabolites, the production of trichothecenes can 
be controlled by environmental parameters such as nutrient availability, oxygen, 
pH, and temperature (104).  From this aspect, it is obvious that many genes 
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exist that can help regulate trichothecene production.  Some of these may 
overlap with other developmental or cellular differentiation processes and 
therefore may be common to secondary metabolism in general and include 
genes not in secondary metabolic gene clusters. 
 
In Aspergillus, a number of such non-cluster genes have been found that 
regulate the production of aflatoxin and sterigmatocystin.  The production of 
aflatoxin occurs in acidic media and is inhibited in alkaline media (21).  It was 
demonstrated that PACC, a protein which represses acid-expressed genes 
under alkaline conditions, bound to the promoter region of the aflatoxin 
transcription factor aflR, and could thereby repress the expression of the 
aflatoxin genes (35, 100).  Global signal transduction pathways are also 
involved.  The fadA gene of A. nidulans encodes the alpha subunit of a 
heterotrimeric G-protein and has been shown to regulate sterigmatocystin 
production and conidiation (47).  A constitutively active form of FadA was shown 
to decrease sterigmatocystin and increase penicillin production in A. nidulans.  
The expression of the same A. nidulans fadA allele as described above, in F. 
sporotrichioides resulted in an increase in trichothecene production and a 
decrease in sporulation (97).  Additional genes outside of the trichothecene gene 
cluster also contribute to the regulation of trichothecene biosynthesis. 
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The possibility of a regulatory gene downstream of Tri5 arose with data 
collected from studies designed to substitute a reporter gene, β-gal, for Tri5.  
This involved a two-step process.  The first step was the homologous integration 
of a vector carrying the β-gal gene flanked by the Tri5 promoter and DNA 
sequence downstream of the Tri5 ORF.  However, comparison of the results of 
upstream and downstream vector integration revealed two phenotypes 
(Beremand, unpublished results).  Only transformants in which the vector 
integrated via the Tri5 downstream flanking sequence, and thus disrupted this 
sequence, displayed an overproduction of T-2 toxin.  This suggested the 
presence of a possible regulatory gene or region downstream of Tri5.  Additional 
studies showed a corresponding overexpression of transcripts from all five Tri 
genes analyzed at that point.  Meanwhile, an examination of the genomic DNA 
sequence from this region revealed the presence of two ORFs downstream of 
Tri5 which could be joined into a single ORF by the removal of a putative intron.  
This ORF was then designated Tri10 (13).  Preliminary Northern analysis 
showed the presence of a transcript generated from these ORFs which was also 
overexpressed in the downstream transformants described above (Beremand, 
unpublished results).  It was at this point that I began my investigations into 
Tri10.   
 
 Chapter II of this work was published in Applied and Environmental 
Microbiology , 67(11), 5294-5302 and details the initial isolation and disruption of 
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Tri10 which I and the other authors completed.  In that study we conclusively 
demonstrated that Tri10 is a positive regulatory gene required for wild-type Tri 
gene expression.  In addition, we also demonstrated that Tri10 is necessary for 
wild-type farnesyl pyrophosphate synthetase (Fpps) gene expression and set 
forth a basic model for the regulation of trichothecene biosynthesis.  The work 
presented in Chapter III investigates the effect of overexpressing Tri10 from 
positions both within and outside the Tri gene cluster and begins to examine the 
effects of Tri10 expression on a larger scale through the use of targeted cDNA 
microarrays.  Finally, I conducted studies which investigated the effects of Tri10 
expression on a key isoprenoid biosynthetic gene in the absence of 
trichothecene production and establishes the role of Tri10 in the regulation of the 
isoprenoid pathway.  This work is presented in Chapter IV and extends our 
knowledge of the regulation of isoprenoid genes by Tri10. 
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CHAPTER II 
A NOVEL REGULATORY GENE, TRI10, CONTROLS TRICHOTHECENE 
TOXIN PRODUCTION AND GENE EXPRESSION* 
 
INTRODUCTION 
 
The trichothecenes represent a large family of toxic secondary 
metabolites produced by a variety of filamentous fungi including Fusarium, 
Myrothecium, Stachybotrys, Trichoderma, and Trichothecium (61).  They are 
primarily found as contaminants in food and feedstuffs and consumption of these 
compounds by humans or livestock results in vomiting, alimentary 
hemorrhaging, and dermatitis (69).  These toxins are potent inhibitors of 
eukaryotic protein synthesis (76) and induce apoptosis (83).  In plants the 
trichothecenes are also phytotoxic and have been associated with virulence in 
specific plant-pathogen interactions (26, 31, 45, 85).  
 
_________________ 
*Reprinted with permission from “A novel regulatory gene, Tri10, controls 
trichothecene toxin production and gene expression” by Tag, Andrew G., G. F. 
Garifullina, A. W. Peplow, C. Ake, Jr., T. D. Phillips, T. M. Hohn, and M. N. 
Beremand.  2001.  Applied and Environmental Microbiology, 67(11):5294-5302.  
Copyright 2001 by the American Society for Microbiology. 
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Significant progress has been made towards determining the 
trichothecene biosynthetic pathway and trichothecene gene organization and 
function.  Trichothecenes are derived from farnesyl pyrophosphate, which is 
cyclized to form trichodiene (36).  The biosynthetic sequence of events 
proceeding from trichodiene to complex trichothecenes such as T-2 toxin has 
been established by a combination of feeding experiments utilizing blocked 
mutants and heavy-isotope labelling of pathway precursors (10).  To date, one 
regulatory gene, Tri6, one transporter gene, Tri12, and all but one of the known 
biosynthetic genes are clustered in Fusarium sporotrichioides (17), and similar 
gene clusters are present in, F. graminearum (17), F. sambucinum (A.W. 
Peplow and M.N. Beremand, unpublished data), and in Myrothecium roridum 
(63).  Tri101, which encodes isotrichodermol 3-o-acetyltransferase, has been 
identified in both F. sporotrichioides and F. graminearum and appears to reside 
outside of the trichothecene gene cluster (66, 72).  In addition to its 
acetyltransferase activity, the heterologous expression of Tri101 in yeast cells 
renders them resistant to trichothecenes (64, 72).  However, disruption of Tri101 
does not appear to cause a loss of toxin self-protection in F. sporotrichioides 
(72), suggesting that other genes can provide this function. 
 
The regulation of trichothecene production is equally complex and like 
many secondary metabolites, can be controlled in liquid culture by the 
availability of certain nutrients, oxygen, pH, and temperature (104), as well as by 
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the modulation of signal transduction pathways mediated by a G-protein Gα 
subunit (97).  However, the complete genetic nature of the induction and 
repression of trichothecene biosynthesis is just beginning to be understood.  
Recently, TRI6, a zinc-finger DNA-binding protein, was isolated, characterized 
(52, 87), and shown to be required for induction of two trichothecene genes (Tri5 
and Tri4) which encode, respectively, the enzymes for the first two steps in the 
T-2 toxin biosynthetic pathway (87).  Here, we report the isolation and 
characterization of a second regulatory gene from within the trichothecene gene 
cluster, designated Tri10, which is required for trichothecene biosynthesis in F. 
sporotrichioides.   
 
MATERIALS AND METHODS 
 
Strains, plasmids, media and culture conditions 
 
The F. sporotrichioides Sherb. wild-type strain NRRL 3299 was obtained 
from the ARS/USDA Culture Collection at the National Center for Agricultural 
Utilization Research in Peoria, Ill. The Fusarium sambucinum Fuckel 
(telomorph= Gibberella pulicaris (Fr.) Sacc.) wild-type strain R-6380 was 
obtained from the Fusarium Research Center, Pennsylvania State University.  F. 
sporotrichioides strains MB5493 (Tri4-) (10, 75) and NN4 (∆Tri6) (87), and the 
Fusarium graminearum Schwein. (telomorph= Gibberella zeae (Schwein.) 
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Petch) wild-type strains GZ3639 (15) and W-8 (85) were described previously.  
Fresh stock cultures were routinely established from frozen glycerol stocks of 
conidia:  Transformants were inoculated onto V8 juice agar containing 300 µg/ml 
hygromycin B and grown in the dark under alternating 12 h 20°C/ 12 h 25°C 
conditions, while all other strains were inoculated onto V8 juice agar and 
incubated under alternating 12 h 20°C dark/ 12 h 25°C light conditions (88).  
Strains were grown in liquid YEPD-2G medium (2% glucose, 0.3% yeast extract, 
1% peptone) for DNA isolation and in liquid YEPD-5 medium (5% glucose, 0.1% 
yeast extract and 0.1% peptone) for trichothecene analysis and RNA isolation 
(88).  The vectors pT7Blue and pCR-Script were purchased from Novagen and 
Stratagene, respectively.  Plasmid pGP53-1 was previously described (49). 
 
RNA extraction and RT-PCR 
 
For RNA isolation, conidia of F. sporotrichioides were washed from 7-day 
V8 juice agar cultures, filtered through sterile muslin, and inoculated into 100 ml 
of YEPD-5 to give a final concentration of 5.0 ✕ 104 conidia per ml.  Parallel 
cultures were grown for 15 h and 23 h (28°C and 200 rpm) and harvested by 
vacuum filtration through P-8 qualitative filter paper (Fisher). The mycelia were 
immediately frozen in liquid nitrogen, lyophilized, and stored at –80°C.  Samples 
were pulverized in liquid nitrogen immediately prior to extraction.  Total RNA was 
isolated using the Ultraspec II kit (Biotecx) according to the manufacturer's 
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protocol with the addition of an acid phenol:chloroform:isoamyl alcohol (25:24:1, 
pH 4.2) extraction following the initial extraction.  For RT-PCR, the purified 23 h 
total RNA was treated with RNase-free DNase I (Ambion) and first-strand cDNA 
was generated from 5 µg total RNA and an oligo(dT) primer using the 
Superscript Preamplification kit (Gibco-BRL).  The Tri10 cDNA was amplified 
from the first-strand cDNA reaction by PCR using oligonucleotides 320 (5' 
ccacccagcaatcatcag 3') and A23 (5' ctgttgtcaataggcgagtg 3'), which lie 22 bp 
upstream and 19 bp downstream of the putative start and stop codons, 
respectively (Fig. 2-1).  A portion of the 3’ end of the Tri10 transcript was cloned 
by pairing primers 516 (5’ cttcagcttatcgggttt 3’) and 356 (5’ gtacctcgtttcatgcc 3’), 
which lie 357 bp downstream of the putative start codon and 192 bp downstream 
of the putative stop codon, respectively.  The PCR amplifications consisted of a 
single cycle of 5 min at 95°C; 25 cycles of 1 min at 95°C, 1 min at 50-55°C, and 
1.5 min at 72°C; and 1 cycle of 10 min at 72°C.  The amplified products were run 
on a 1% agarose gel and purified using the Qiaquick gel extraction kit (Qiagen).  
The purified products were then cloned into pCR-Script (Stratagene) and 
sequenced. 
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TRI4 TRI6 TRI5 TRI10
TRI5 TRI10
1743 1158 654 2277 1185 619 1340 
ATG ATG TAA TGA
A1 320 516 A23 356
420 aa 
  FIG. 2-1.  Graphic representation of the location of Tri10 and position of primers used for RT-
PCR and for vector construction.  Gray areas indicate intergenic regions while the crosshatched 
areas represent the relative positions of introns within Tri5 and Tri10 in F. sporotrichioides.  The 
numbers at the top of the figure indicate base pairs. 
 
DNA sequencing 
 
Cloned RT-PCR products and genomic DNA clones were sequenced 
using specifically designed primers.  Tri10 of F. sambucinum R-6380 was 
sequenced from plasmid pGP53-1, which contains a 4.7-kb EcoR I fragment 
(harboring Tri5 and downstream sequences) isolated from a λgt11 library (49).  
Tri10 was also shown to be present and downstream from Tri5 in F. 
graminearum GZ3639 by Southern hybridization using the F. sporotrichioides 
NRRL 3299 Tri10 homolog as a probe.  This downstream DNA, which is located 
on a 3.5 kb HindIII fragment, was amplified by chromosome crawling (89) via 
inverse PCR using two primers, B-1 (5'gcgacgctcgataccgcctcc3') and B-2 
(5'cgtgtccatcacctgagggtcc3'), corresponding to the Tri5 gene from F. 
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graminearum strain W-8 (85). All sequencing reactions were performed using 
the ABI PRISM Dye Terminator Cycle Sequencing Core Kit or the BigDye 
Terminator Cycle Sequencing Core Kit (Perkin-Elmer Corporation).  Reactions 
were run on a Model 373A or Model 377 DNA Sequencer (Applied Biosystems) 
by the Gene Technologies Laboratory at Texas A&M University. 
 
Plasmid construction and fungal transformation 
 
The Tri10 gene disruption plasmid, pTri10-1 (Fig. 2-2), was constructed in 
two steps.  First, the PCR fragment (A1-356) (Fig. 2-1) containing the Tri10 
coding region and flanking sequences was cloned into pT7-Blue.  Then, the 
Tri10 amino acid coding region was disrupted by removing a 101-bp BstB I-BstE 
II fragment and replacing it with the Cochliobolus heterostrophus promoter 1 
fused to the hygromycin B phosphotransferase coding region (103).  For fungal 
transformation, protoplasts were isolated by the following procedure:  Conidia (1 
to 5 ✕ 108) were inoculated into 100 ml of YEPD-2G broth and incubated for 7 h 
at 28°C with vigorous shaking (200 rpm).  Germlings were harvested by filtration 
on a 0.2 µm cellulose nitrate filter, washed once in 25 ml 0.7M NaCl, and 
resuspended in 20 ml 0.7M NaCl containing 0.1% 
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TRI10
TRI10
TRI10 TRI10
hygB:P1 
hygB:P1 
hygB:P1 
pTRI10-1
 
  FIG. 2-2.  Results of integration of pTri10-1 into the Tri10 gene.  Integration via (a) double  
and (b) single upstream homologous crossover events. 
 
 
Novozyme 234 (InterSpex Products), 1% driselase (Sigma) and 0.025% 
chitinase (Sigma).  The germlings were then incubated at 28°C for 20-60 min 
with gentle shaking (75-90 rpm) until most of the culture had been converted to 
protoplasts. Protoplasts were collected by centrifugation (1100 x g) for 5 min at 
room temperature and then washed once in 0.7M NaCl and twice in STC buffer 
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(1.2M sorbitol, 10mM Tris-HCl, 10mM CaCl2). Transformation was performed 
according to the procedure described by Salch and Beremand (88). 
 
DNA isolation and analysis 
 
 Fungal genomic DNA was isolated as previously described (49).  
Southern blots were prepared according to standard techniques (89) using DNA 
digested with Hind III, which cuts the vector pTri10-1 once, and Bgl II, which 
does not cut the vector.  The resulting blots were first hybridized with 
radiolabeled ([
32
P] dCTP) DNA probes prepared by nick translation (Gibco BRL) 
and then washed as recommended (Gene Images, USB). 
 
RNA analysis 
 
For RNA blots, 5 µg of total RNA was separated by electrophoresis on 
formaldehyde-containing 1% agarose gels and transferred to Hybond N+ 
(Amersham) nylon membranes (89).  Probes for RNA blots were gel-purified 
PCR fragments radiolabeled with [
32
P] dCTP by nick translation (Gibco BRL). 
 
T-2 toxin analysis 
 
Duplicate YEPD-5 liquid cultures (25 ml) were inoculated and grown in 
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parallel as described above for RNA extraction.  After 7 days of growth, a 5-ml 
aliquot of whole culture material was removed and frozen at -20°C until 
analyzed.  T-2 toxin was extracted by vortexing 2 ml of whole culture material 
with 2 ml of ethyl acetate for 90 s.  The phases were separated by centrifugation 
at 1100 x g for 5 min.  Supernatants were removed and diluted with ethyl acetate 
to various concentrations and  analyzed by gas chromatography-mass 
spectrometry (GC-MS) on a Hewlett Packard 5890 GC equipped with an HP 
5972 MS engine. Samples were introduced via a heated injection port (260°C) 
with an HP 7673 autosampler (2 µl injection volume) into an HP5-MS bonded 
stationary phase capillary column (30 m X 0.25 µm internal diameter) with a film 
of 0.25 µm thickness. The oven temperature program began with an initial oven 
temperature of 90°C for 2.0 min, followed by a ramp (23°C/min) to 275°C for 2.0 
min. The temperature was then increased (30°C/min) to 290°C and held for 4.7 
min.  Helium was used as the carrier gas at a constant flow rate of 0.75 ml/min.  
The mass selective detector was used in either ion-selective mode (T-2 toxin 
quantitation) or full-scan mode (to obtain full spectrum) with an ionization energy 
of 70 eV and an ion source temperature of 180°C.  Identification of T-2 toxin was 
based on retention times and spectra compared to those of standards.  T-2 toxin 
was purchased from Sigma Chemical Co. (St. Louis, Mo.) and used without 
further purification.  Toxin levels of transformants were compared to the wild 
type by a priori contrast using the JMP4 statistical software package. 
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T-2 toxin sensitivity assays 
 
F. sporotrichioides strains were tested for resistance or sensitivity to T-2 
toxin by using three different assays.  In the first assay, designated the drop-
plate assay, T-2 toxin solutions were prepared in ethyl acetate to yield a 
concentration of 10, 25, 50, or 100 µg per 25 µl solvent.  A 25-µl sample of each 
concentration and a solvent control were individually spotted on the surface of a 
YEPD-2G agar plate (2% agar, 10 ml agar per 100 mm plate) and allowed to 
evaporate.  The plates were immediately inoculated with the desired strain by 
spreading 100 µl of a freshly prepared conidial suspension containing 1 to 2 x 
106 conidia/ml and then incubated for 2 days in a growth chamber with an 
alternating 12 h 25°C light/ 12 h 20°C dark cycle.  The second assay was 
conducted on GYEP agar (=YEPD-5 in this study) as previously described with 
the exceptions that plugs of mycelia were used for inoculation and that T-2 toxin 
was used instead of diacetoxyscirpenol and only at a 100 µg/ml  concentration 
(4).  The third T-2 toxin sensitivity assay was conducted in liquid media.  T-2 
toxin stock solutions of 40 mg/ml and 20 mg/ml were prepared in ethyl acetate 
and 25-µl aliquots of the appropriate concentration were added to make 1-ml 
aliquots of both YEPD-2G and YEPD-5 with final concentrations of 1000 and 
500 µg/ml T-2 toxin.  Aliquots of both media were also prepared with 25 µl of 
ethyl acetate as controls.  Additionally, spent YEPD-5 media from 3-day cultures 
of NRRL 3299 and FsTri10-1-25 (this study) were analyzed by GC/MS to 
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quantitate the amount of T-2 toxin present and aliquots were sterilized through a 
nylon 0.2 µm filter.  All media were transferred to a 96-well microtiter plate (150 
µl/well, in duplicate/strain) and inoculated with 7 µl of condia of NRRL 3299, the 
∆Tri6 strain, or the ∆Tri10 strain to bring the final concentration to 1 X 103 
conidia/ml.  Cultures were grown on a gyratory shaker with vigorous shaking at 
28°C for 3 days.  The response to T-2 toxin was determined by following optical 
density at λ=595 at selected time points.  A complete lack of increase in optical 
density corresponded to a complete lack of growth as confirmed by visual 
examination of the cultures. 
 
Nucleotide sequence accession numbers 
 
The nucleotide sequence and the predicted polypeptide sequence for 
Tri10 from F. sporotrichioides, F. graminearium, and F. sambucinum have been 
submitted to GenBank (accession nos. AF364179, AF365969, and AF386074, 
respectively). 
 
RESULTS 
 
Identification & sequence analysis of Tri10 
 
Using mutant analysis and genomic DNA sequence from the  
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trichothecene pathway gene cluster in F. sporotrichioides, Beremand and Hohn 
previously identified a potential 1,260-bp open reading frame (ORF) 619 bp 
downstream of the Tri5 stop codon which they designated Tri10 (M. N. 
Beremand, unpublished results) (13) (Fig. 2-1).  RNA blots probed with labeled 
DNA fragments from this region revealed the low-level production of a transcript 
from the predicted ORF as seen in Figure 2-3.  In this study, the F. 
sporotrichioides Tri10 transcript was amplified by RT-PCR, cloned, and 
sequenced, confirming a 1,260-bp ORF encoding a putative protein of 420 
amino acids and a predicted molecular weight of 47,427 Da.  Comparison of the 
genomic and cDNA nucleotide sequences indicated the excision of the predicted 
77-bp intron from the coding region of all transcripts (bases 379-455) as well as 
the excision of a 69-bp intron from the 3' untranslated region (bases 1424-1492) 
of some of the transcripts.  Interestingly, at least one other trichothecene gene, 
Tri12, contains an intron in the 3' untranslated region (4).  Both Tri10 introns 
contain the consensus splicing signal sequence GT::AG for filamentous fungi, 
but only the 77-bp intron contains a consensus branch point (44).  
 
Tri10 is transcribed in the same direction as Tri5.  Two putative TATA 
boxes are present at positions -44 and -111 from the predicted translational start 
codon (Fig. 2-4).  Five putative CAAT consensus sequences are located at 
positions -32, -48, -50, -107 and -207.  A consensus eukaryotic ribosome-
binding site exists beginning at position -6.  No polyadenylation signals were 
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found downstream of the stop codon. Comparisons of both the nucleotide 
sequence and predicted amino acid sequence against multiple protein and DNA 
databases yielded only a single possible match (tBLASTn score=93, Evalue=4e-
17) (6) to a pair of nearly identical ESTs (AL113997.1, AL1116861.1) of unknown 
function from Botrytis cinera grown under nitrogen-limiting conditions. 
 
 
TRI10 
TRI6 
TRI5 
TRI4 
TRI101 
FPPS 
rRNA 
15 15 15 1523 23 23 23
Wt ∆TRI10 ∆TRI6 ?TRI10
 
  FIG. 2-3.  Northern analysis of ∆Tri10, ∆Tri6, and 
↑Tri10 strains.  Northern analyses of Tri10, Tri6, 
Tri5, Tri4, Tri101 and Fpps in wild-type (NRRL 
3299), ∆Tri10 (FsTri10-1-12), ∆Tri6 (NN4), and 
↑Tri10 (FsTri10-1-20) strains of F. sporotrichioides 
grown in parallel for 15 and 23 h.  5 µg of total 
RNA was loaded per lane.  Ribosomal RNAs were 
visualized in the gel by ethidium bromide staining. 
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F.sp.-703ccgaaggtg-gtttggaagtatgttttgcgggtac------tcgctaggagaatactggccatttatcatgattacaaatagcttggttttgttttttat 
F.sa.-703....c....-aga......................------..................t.g...........................g.......-.. 
F.gr.-703.......c.a.........................ggatac...t.t.......gg...t.tg....a..............t.c...cg......g—. 
 
F.sp.-603tagtctagaatgtacggttgaacaaggataattactacaggataggcagtgtgaactgg-tttttgaa----acccgagcctgtaagcat—cccacttg 
F.sa.-603...c-----..t...a.................c....t.a........ctga.....a-.g.c..t.----..t.c.......tc.tta--t..g.... 
F.gr.-603...a-----...a..a....................t.g.a.........tga.....aa.g.c..t.cgta...t..........c...tt........ 
 
F.sp.-503actgcagggcttttgcatggctgcctaggttatacctgttacggtctcagtgcgacagggctatcc------cggct-ctgc-------gccgcag---- 
F.sa.-503c.......t....-.......caag.catagt...........a.g..g.................ataccc....c-.g..ct-----..t.t..a--- 
F.gr.-503 g......-.......g.aa.caag.ct..-.c...c..--------.g..............c..ccaacc.t..aa....atctgca..t....ctgg 
 
F.sp.-403--------tag----ccgct-----ctgtagtgtggtgccgggaatcttctacccgatcggaggcctggggaactt-gttttacaccgagtttacgcatt 
F.sa.-403-------g...----g...cacggc........c.c...-..........c...t.t.....t.--....a.gt..t.....c.t.g.g.c.a..aa... 
F.gr.-403cagactgg...actgg....acgaa........c.a...-.........g......c.......----------------..gg.gg...c.gg.a.... 
 
F.sp.-303cc----agccgtgtctt---cttcaaatcgct--------------------gacctagatccatgtctacttgttccatctaa-cgttcattgaacaag 
F.sa.-303..----.a..a.taa..gat.......g....tgcgtttgctctatatggcc.g..ct.....tg..a..t..tca....a.gg-.a..ttc..c..... 
F.gr.-303.tctag.c...c.aa..gat.......g....tgcgttttgtccagatcagt....-.t.c..t.....tt.c.ca...c.c..a...c..c.....g.. 
 
F.sp.-203gcgtacagaaaccgcaccaagtaaagtctcatgcccgctcaaccaccactgggtacacggcacatctgttaaactctatccttgcattatattgtaacat 
F.sa.-203.............a...g.g.......t...c.......tg.....t.tc..aa.....a...aca....g............................. 
F.gr.-203.............a...a.ga...gg.t.g.....t...tg.g...t.tga..g.....a...t.....a.............................. 
 
F.sp.-103cgcctaacttctccacgcactattctttcgtgttttttatccaacctcaattgtataccacccagcaatcatcagattactatttct------gttagtc 
F.sa.-103........a................c..t.c...cc...ct..t......c.a...g...a...a.....g...a....tc...g.a------....... 
F.gr.-103..tt....t.........-.c....c...cc..c...ccc.....t..........g...a...a.........a....tc...at.attgtc....... 
   +1 
F.sp.-3  atcATGGAATTTCCGAAGCCGAGACAGTTCAGAGAGACGAGTCTGTTGATGTACTACCTGGACGTCGTGTTTCCTCTGCAATACATTTCACCAAACAACA 
F.sa.-3  ..a.....T..C..A........G...G.T...........C..............................T....A....GT...A.C.......... 
F.gr.-3  ........T..C..A.....T.....AG..C..........C.................A......................G...CAAC.......... 
 
F.sp.97  ATTGTCTGGGGAAAAGAGAGTGGTTGTTGACTATACTAACTTCTGCTCGCCCTACATACTATGCAACATTGTGCCTGGCCCTCCTTTATAAAGAGTCTCT 
F.sa.97  ..........C..G.........C................C........G.....T....................T.................A..C.. 
F.gr.97  ..........A..G.........C.............G..C.....G..G.....G........C.........A..T.G.....C........A..G.. 
 
F.sp.197 TTCAACCTCGTGCAGAAGTGAACAAACATTAGTATGGAAGAGGGAAAAGACCTACTACTACATTCTTGCGCTCCAGGAGTCTCAAAAGCTCTTGGGTGGG 
F.sa.197 .....G.C.T......GC......GG.GG.............A................................A........G.....G........A 
F.gr.197 .....G.C.T......TC......GG.GA.G...........A..G.....A.................A..............G.....GC........ 
 
F.sp.297 CTTAACAAGACCTTTGGTATCACAAGGCTGAAAGGGACGGTCGTTGCCCTCGCTTGCATGCTTCAGCTTATCGGGTTTGAGgtaagacgaatccaccat- 
F.sa.297 ..CG.......T.................A..G.....C...A.......T.........A.C.....C..C........................a.c- 
F.gr.297 ..CG.......A.....C.................T..C...........T...........A.........A.T........................t 
 
F.sp.397 ------------gactacgatgttcaataccagatgtataattattgttggcgactaacgcattgcgacagTCTTCGCACCTGAGTAGGGGAGATTGGCG 
F.sa.397 ------------.ctc..a............c...c..........t....a.............g.a............T.A................. 
F.gr.397 gtttcgatgctc..tgt.....c..g...t.c...c..cg.....c.....tc......aa...aaa.t.............A..C.............. 
 
F.sp.497 TGTTCACCTCCTTGCTGCCAACACACTCATTCCTGTGTTGGCCGAGGGTTGGTCCACAGCTTTGCAGTCAGGCCCCCCAGCCACTTCCATATGGTGTGAG 
F.sa.497 C..............A.........................T........................A........T...........A..C......... 
F.gr.497 C..........A...G.......T............C....TT.....A.................A.................C...........C... 
 
F.sp.597 TTAGACGAATCGGACTTTGATTCAATCGACGATCAGACCTCTTTGAGCTTCGAATATCTCGGAGCTTTGAGATTCCTGTCGAACTCCTTGGCGAAAATCG 
F.sa.597 ..G.....TC....T..C.GC....CT..A.....A.AT..C.................T..T............T....A......C......C..C.. 
F.gr.597 C.G..T.....AC....C.GC..G.CT..A.....A....................CG......................A.....AC.C..CGC.G... 
 
F.sp.697 GCATCTTATCTTGCATATCTGTTGGTCCAGCAGCGCCATTTGAAGACTATGGTCACCTCCTGGACCAGCCAGGCCTGATACAGCTGGAAGAGGTACTGGG 
F.sa.697 .T........A........G.........T....A..G..C.....T....T.......T.A..............C......A....T.....G..A.. 
F.gr.697 .....C.G............A....C...T....A...........T..C..C..T.T..................T...........C.....G..... 
 
F.sp.797 GTGCAAGAACTGGGCCATGCTGACTATTCTTGAAGTGGGTAAGCTGGACAGGTGGAAGCGCCAGGAGCAGGAACATAACCGTTTGAGCCTGAAGACACTT 
F.sa.797 .......................G...A..C..................C.........A.........A..G..C..............A........C 
F.gr.797 ....AG...T...A.....T..........C.................TC.T........A........A........T..C........A.....G..C 
 
F.sp.897 GCTATGCGCGCAATGATTATAGAGGATATGTTGACAGACGAACTACAAAAACTTCCGACAAGCGAGACGCTACCGGATCTGATCACCCACATTTACGCCG 
F.sa.897 ....G...T........G........C..............G........G..G...G...A.........G.....C..C........T.......... 
F.gr.897 ....G......C.....G..T............T.......G.......GG..A......GA.........T..A..C..C.....T..G.......... 
 
F.sp.997 CCTCTATCGCGACATACCTGCATACAGTAGTTTCAGGACTGAATCCCAACCTTTCAGAGGTCCAGGATAGCGTGTGCGCAACAATATTATTGTTGGAGAG 
F.sa.997 ....C..TAT..C...........................C.............................T...A.T.....G..CC.........G... 
F.gr.997 ........AT...G..T.................C.....C....................T........T...GC..GG..GC.TCA............ 
 
F.sp.1097GCTCCCAGACTTGCAAGCTGTCGCGAGCGTTACTTGGCCTTTGGCTGTCACGGGGTGTATGGCTTCAGAAAGTCATAAGGACTTTTTCAGAAGTACTCTG 
F.sa.1097A........TC..............TCT...............A.......A..TT.......C.........................A..C....... 
F.gr.1097.......A.TC.TG........A.................C.A........A..A..C.....C............................A....... 
 
F.sp.1197AGGTCTTATGAAGCGACATTCAGCTCGTTAAAGAAGTACGACGGAGTTCTTGAGGTGTTGGAAGATGCTTGGAAGAAAAGAGAGGTAGATACAGAGTCTC 
F.sa.1197..A........C.G........C...C..G..A.....T..T...AC.........T........C........C.G.CGT...A....C.G........ 
F.gr.1197.....G.....G..............C.....A.....T......AC....C....C........C..........G.......A............... 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  FIG. 2-4.  Sequence alignment of Tri10.  Sequence alignment of Tri10 from F. sporotrichioides 
(NRRL 3299), F. sambucinum (R-6380), and F. graminearum (GZ3639) produced using Multiple 
Sequence Alignment (Baylor College of Medicine [http://dot.imgen.bcm.tmc.edu:9331/multi-
align/Options/map.html]).  Dots indicate conserved bases with F. sporotrichioides, dashes indicate 
gaps between species.  Captial letters indicate the putative amino acid coding region.  A single 
underline indicates intronic sequences.  A double underline indicates conserved putative TATA 
elements and a wavy underline represents conserved putative CAAT elements.  The boxed region is 
the conserved ribosome binding site.   The conserved TRI6 binding site is indicated by boldface type.
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F.sp.1297CAATGAGGTGGGAGGATTTGATGGATCACCATGGGCTTCCAGTGCTCCTTTTCTAAggatgacattaccccttgacactcgc-ctattgacaacagagat 
F.sa.1297....CC...........C.A...........C.................AC....G..t..gt..c.t...ca........tg...cca...-......c 
F.gr.1297.......A.....A..C....C..........A.............A....GG..Gaatt.ttggagagg..ccca.a..ttgaagc..t..--c...cg 
 
F.sp.1397tatctgtagtatttctcatgcatgagctaccc-atttgtgtaagtttggtgctcacttaccaatgatacggtcagagaagtctcattagcgcttacggat 
F.sa.1397.....tg...c...a.tt..t..ac......tg...ca..-.....c....t......g..g.......at....g.......g.c...tcag.t.tt.. 
F.gr.1397.ta..tg-.cc.c.ag.tgt..cag.a.g.atggcc.ca.a....cataa.ga.tt..t.ag.a-....tc.g..-.tc..a.g.ggc.aca..-.a.c. 
 
F.sp.1497cgttttagt--ttttggtgtta--aaccaatattggcatgaaacgaggtacgatcgtcttgtgatcgaagagcgagtaactactcagatgtaacttagat 
F.sa.1497g...gg.t.cc......c....ta....gggt...t....g.g.a..a..t...ttcga..a..gg.........ac.....t...c..a......aa.. 
F.gr.1497.c..aa.aaa-g.a..ac.g----...tct.cag.t.t..g.---..--...-----....ga.ga......a..-..ga...ag..tctcc.a.g.... 
 
F.sp.1597tgtatacttttgatatagacttccaacatagattttcgattgtaagccgcgtcttatctaagtatgtacatccaaccagctgtgctgaaagtagtctgaa 
F.sa.1597.-------------........t..gt...atc......g.a........act.a..........a.........t..at...a.c............g. 
F.gr.1597g.------------ga......gacgg..cacca.ag.c..cc.g--t..ta...tgg..g.g...gt-...g--------.c..a..g.c..--.g..t 
 
F.sp.1697agcatgatgagctaatcagttctgtattcccttatagtcttaacatgatttgacttgttcagcccgtaaaacacacgatactgataatg-gtgagggagt 
F.sa.1697.t....g.tgt.-....g..g....g....tcc...t....g.............g....g.t...cgcg.........gt....c..a-a...a..... 
F.gr.1697.c.--...acc.g..---..-..t.c...-tgc..cag..--..cc...---..a...aagtt---.g.tg.t...t-...a...g...ca..ca..gaa 
 
F.sp.1797gttgactttggccgcgggaagttattgt-gttccctgcaacgatcgttcggaacgaaacacggttggagcaaggttttttcgtgggccggaaatgggaga 
F.sa.1797.....t....agtag.aa...a.a.c.ca.....t..t..a...g..............c..tc.....t.t.a...g.......a..c...gca.a.a. 
F.gr.1797...tta..a.--------.t.....g.--....g----.ctc..t-..g.cgttt.....g..a.t.-...t.acgca.gat.ta.at....-.a.a... 
 
F.sp.1897atgctggaa-cgagcgacaggtaaatctatccaatttggcttggaacg-cgatgtcggtctgcttctttctaatggagagttgatatcg--catct-tca 
F.sa.1897....c.a..-tt.at......c.t-...c.t.....-.......gtt.-a.g.a.t.......g...g.----....a..c...cg.t.--g....-... 
F.gr.1897--..g.a..a..tttcc..t....c.-.gaatg..gg.a...tc..tatat..t..taga.a...t...aaccc...acccgc..c.tctt.....a... 
 
F.sp.1997gcatgccttggctgcgacccaaa-tggt----tgcgcataaagcagcgctaactcctgagtatgcgaaaacctctagccacgaaacatcagggtccatct 
F.sa.1997a.a...t..t..c..........-....----.........g........g.....c.................g.....t.................t. 
F.gr.1997c..at.g.--....aa.g...gtc...aaccat.g.ggcg..a..ag...gggc...tg.a....t----.ga.at.g.tt..c.ttgttaacc..g..g 
 
 
 
 
Transformation with pTri10-1 leading to the disruption and displacement of 
Tri10 
 
The effect of Tri10 gene disruption on Tri gene expression and toxin 
production was examined next.  However, in previous work the homologous 
integration of a Tri5 gene replacement vector into the Tri5 downstream 
sequence resulted in an increase in trichothecene gene expression and toxin 
production (M. N. Beremand, unpublished). Since this vector contained the 
downstream region of Tri5 beginning with the last few codons of Tri5 and 
extended into what is known to be the middle of the Tri10 gene, we designed the 
pTri10-1 vector so that it could either disrupt Tri10 as a result of homologous 
integration via a double crossover event, or essentially duplicate the 
FIG. 2-4. Continued 
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homologous integration event described above via a single crossover event (Fig. 
2-2).  Accordingly, the pTri10-1 vector carried a 2.1-kb DNA fragment which 
began at the end of the Tri5 amino acid coding region and included the entire 
Tri10 gene except for a 101-bp amino acid coding segment which was replaced 
by a hygromycin resistance cassette.  Southern blot analysis (data not shown) of 
the hygromycin-resistant transformants obtained following transformation of the 
wild-type F. sporotrichioides NRRL 3299 strain with pTri10-1 revealed that both 
classes of transformants were produced. 
 
Tri10 plays a major role in controlling toxin production and the 
transcription of known trichothecene cluster genes and Tri101 
 
To investigate if disruption of Tri10 had an effect on T-2 toxin production, 
we grew YEPD-5 liquid shake cultures for 7 d and measured the culture filtrate 
for T-2 toxin using gas chromatography-mass spectrometry (GC-MS).  
Transformants which contain a single disrupted copy of Tri10 (∆Tri10) 
consistently produce no T-2 toxin as seen in Table 2-1 and do not appear to 
accumulate trichothecene pathway intermediates (data not shown).   
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TABLE 2-1.  Production of T-2 toxin by Tri10 transformants. 
___________________________________________________________ 
Groupa Strain   Amt of T-2 toxin (µg/ml)b 
_____________________________________________________ 
Wild type NRRL 3299  267±5 
 
∆Tri10  FsTri10-1-12  0 
↑Tri10  FsTri10-1-8  566±5 
  FsTri10-1-16  604±46 
  FsTri10-1-20  633±14 
  FsTri10-1-23  418±7 
  FsTri10-1-24  644±6 
  FsTri10-1-25  999±137 
_____________________________________________________ 
aEach group was shown to be significantly different by a priori contrast.  
bValues shown represent the mean of duplicate extractions of duplicate cultures 
± the standard deviation. 
 
 
In contrast, transformants resulting from a single homologous integration 
event in the upstream portion of Tri10 displayed a significant (p=0.0003) 
increase in T-2 toxin production in comparison to the wild-type strain (Table 2-1).  
The observation that T-2 toxin production is substantially elevated in these 
transformants parallels our previous and subsequent observations with 
integration events in this region of the gene cluster.  Thus we have designated 
this group of pTri10-1 transformants as Tri10 overproducers (↑Tri10). 
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RNA blot analysis was employed to examine the effect of the disruption of 
Tri10 on Tri gene expression.  Comparison of transcript levels of representative 
Tri cluster genes between the ∆Tri10 transformant (FsTri10-1-12) and the wild 
type showed that the expression of the trichothecene biosynthetic genes Tri5 
and Tri4 and the regulatory gene Tri6 was greatly reduced in the ∆Tri10 strain 
(Fig. 2-3).  The Tri5, Tri4, and Tri6 gene transcripts are not detectable in the 
wild-type strain at 15 h but reach a high level of accumulation by 23 h.  In 
contrast, only low levels of these gene transcripts appeared in the ∆Tri10 strain.  
Full expression of Tri101, a Tri gene which putatively lies outside of the Tri gene 
cluster, was also dependent upon Tri10.  While Tri101 is expressed at the same 
level at 15 h in both the wild-type and the ∆Tri10 strains, the level of Tri101 
transcript increases at 23 h in the wild-type strain but not in the ∆Tri10 strain 
(Fig. 2-3).  The transcription of Tri10 is also effectively blocked in the ∆Tri10 
strain.  The trace amount of hybridizing material observed in the 23h sample is 
most likely from a fusion transcript with the 5’ end of Tri10 joined to the P1:hygB 
sequence inserted in the Tri10 coding region (Fig. 2-2). 
 
Examination of this same set of Tri gene transcripts in the ↑Tri10 
transformant FsTri10-1-20 revealed that all of these transcripts are at least 
slightly elevated compared to the wild type at 23 h (Fig. 2-3).  Notably, the Tri10 
transcript is obviously elevated.  Collectively, these data further demonstrate that 
T-2 toxin production parallels Tri gene expression and support the hypothesis 
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that Tri10 plays a major regulatory role in coordinately regulating Tri gene 
expression and T-2 toxin production. 
 
Tri6 is not required for transcription of Tri10 
 
Interestingly, Tri10 appears to be overexpressed at both time points in the 
Tri6 disruption mutant NN4 relative to the wild-type strain as seen in Figure 2-3.  
This is in sharp contrast to the other Tri genes, which show a marked decrease 
in the amount of transcript in response to the disruption of Tri6.  These data 
suggest that the transcription of Tri10 is not positively regulated by TRI6, but 
instead may be negatively regulated either directly or indirectly when TRI6 is 
present. 
 
Tri10 gene expression indirectly controls Fpps gene expression 
 
To determine if Tri10 gene expression affects the expression of genes in 
the primary metabolic pathway that directly feeds into the trichothecene 
biosynthetic pathway, we examined the expression of Fpps.  FPPS catalyzes the 
formation of farnesyl pyrophosphate, the last intermediate in the isoprenoid 
primary metabolic pathway and the immediate precursor to trichodiene, the first 
intermediate of the trichothecene biosynthetic pathway.  As seen in Figure 2-3, 
Fpps transcript levels are reduced in the ∆Tri10 transformant and slightly 
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elevated at 23 h in the ↑Tri10 transformant.  It is also noteworthy that the Fpps 
transcripts are reduced in the ∆Tri6 transformant even though Tri10 transcripts 
are elevated.  This suggests that Tri10 does not directly control Fpps transcript 
levels, but rather does so indirectly via its control of the expression of Tri6, 
another gene(s), or trichothecene toxin levels. 
 
Tri10 expression affects self-protection from T-2 toxin 
 
The results shown in the drop plate assay (Fig. 2-5) indicate that the 
deletion of Tri10 reduces the level of T-2 toxin self-protection and suggest that 
the expression of Tri10 may be required for wild-type levels of T-2 toxin self-
protection.  Unlike the wild-type parent, the ∆Tri10 strain clearly displayed 
reduced growth in the presence of 100 µg and 50 µg T-2 toxin.  To determine if 
this response was mediated through the lack of Tri6 gene expression and hence 
the lack of expression of a gene(s) under the control of Tri6, or simply due to the 
lack of T-2 toxin production, the ability of a ∆Tri6 strain and a Tri4- strain to grow 
in the presence of T-2 toxin was examined.  Although both strains fail to make T-
2 toxin, the ∆Tri6 strain does so because it is blocked in the transcription of the 
known Tri cluster genes, and the Tri4- strain does so because it does not make 
an active trichodiene oxygenase enzyme and is therefore blocked in the second 
enzymatic step (feeding experiments have shown that this Tri4- strain expresses 
all of the other pathway enzymes and therefore the genes) (75).  As seen in 
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Figure 2-5, the ∆Tri6 strain showed an even greater sensitivity to T-2 toxin than 
did the ∆Tri10 strain, while the Tri4- strain looked like the wild-type parent.  We 
also examined T-2 toxin sensitivity using the YEPD-5 plate assay described by 
Alexander et al (4), with the exceptions that T-2 toxin and mycelial plugs were 
used.  Under these test conditions we saw no difference between the growth of 
the wild-type strain and either the ∆Tri6 or ∆Tri10 transformants on media 
containing 100 µg/ml T-2 toxin (data not shown).  Because we had observed a 
discernible difference between these strains and the wild-type strain in the drop-
plate assay, we performed a third assay utilizing both YEPD-2G and YEPD-5 
liquid media as well as spent YEPD-5 media containing known amounts of T-2 
toxin.  The results of this assay are shown in Figure 2-6.  Both the ∆Tri10 and 
∆Tri6 transformants can be distinguished from the wild-type parent.  However, in 
contrast to the ∆Tri6 strain which demonstrated no growth at all in the YEPD-2G 
(1000 µg/ml T-2 toxin) and the spent media, the ∆Tri10 strain was able to grow 
under these conditions, albeit in an altered fashion, as measured by optical 
density. 
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  FIG. 2-5.  Drop-plate T-2 toxin sensitivity assay.  25µl of ethyl acetate containing (a) 0, (b) 10, 
(c) 25, (d) 50, or (e) 100 µg T-2 toxin was spotted onto YEPD-2G plates and the ethyl acetate 
was allowed to evaporate.  The plates were then spread with 1 to 2 x 105 conidia and allowed to 
grow 2 days. 
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  FIG. 2-6.  Microtiter plate T-2 toxin sensitivity assay.  Wild-type (NRRL 3299)(?), ∆Tri10 (■), 
and ∆Tri6 (▲) strains were grown in YEPD-2G and YEPD-5 containing either 1000, 500, or 0 
µg/ml T-2 toxin. These strains were also grown in spent YEPD-5 media containing 264 or 534 
µg/ml T-2 toxin.  All strains were grown for 64 h and the optical density was measured at λ=595.  
Error bars represent the range of readings observed per isolate per time point. 
 
 
The above experiments indicate that the assay conditions are critical for 
observing the increased sensitivity of both the ∆Tri10 and the ∆Tri6 strains to T-
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2 toxin.  Overall, the ∆Tri6 transformant was more sensitive, showing clearly 
inhibited growth in 2 of the 3 assay formats, while the ∆Tri10 transformant was 
intermediate between ∆Tri6 and wild type, only showing some clearly inhibited 
growth in the drop plate assay.  These results, together with the observation that 
a low level of the Tri6 transcript was present in the ∆Tri10 transformant, imply 
that Tri10 via Tri6 controls the expression of one or more genes that contribute 
to T-2 toxin self-protection and that the wild-type levels of expression of these 
genes only become essential under certain growth conditions. 
 
Tri10 is conserved in other trichothecene-producing Fusaria 
 
To determine if Tri10 was present in other trichothecene-producing 
species and also to ask what motifs within Tri10 might be conserved, we 
examined the genomes of F. sambucinum R-6380 (G. pulicaris), which produces 
primarily diacetoxyscirpenol, and F. graminearum GZ3639 (Gibberella zeae), 
which produces primarily deoxynivalenol.  We isolated and sequenced Tri10 
from both of these strains as described in the materials and methods and 
determined that the placement and direction of transcription relative to Tri5 is 
conserved.  Likewise the amino acid coding sequence of Tri10 in F. 
sambucinum and F. graminearum is of identical length to that found in F. 
sporotrichioides and all three species share >85% nucleotide identity (Fig. 2-4) 
and approximately 88% amino acid identity.  All three species share at least one 
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putative TATA and CAAT element (Fig. 2-4).  They also share the conserved 
eukaryotic ribosome-binding site (with one nucleotide substitution), conserved 5' 
and 3' splice sites surrounding the intron within the coding region, and the 
conserved branch point within the intron (51) (Fig. 2-4).  However, the removal 
of this intron has not been confirmed by cDNA sequencing in F. sambucinum or 
F. graminearum.  In addition, F. sambucinum and F. graminearum appear to 
lack the consensus splice sites for the intron in the 3' untranslated region. 
 
DISCUSSION 
 
In this study we define a key regulatory gene, Tri10, which controls 
trichothecene production and related gene expression.  As depicted in the model 
in Fig. 2-7, the data suggest that Tri10 exerts this control, at least in part, by 
regulating the transcription of Tri6.  Tri10 appears to be a positive regulator of 
Tri6 since Tri10 transcripts appear before Tri6 transcripts in the Tri10 
overproducing strain and deletion of Tri10 severely inhibits trichothecene gene 
expression and blocks trichothecene production.  However, because disruption 
of Tri10 does not cause a complete loss of Tri6, Tri5, Tri4, and Tri101 gene 
transcripts, and the disruption of Tri6 likewise only causes a severe reduction of 
the latter three gene transcripts, each of these genes must also have an 
additional basal route or mechanism by which their expression is activated.  
Furthermore, in order to account for the lack of T-2 toxin production by the 
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∆Tri10 strain, the loss of Tri10 must completely block the transcription of some 
additional gene(s) required for T-2 toxin production.  Alternatively, a combined 
marked reduction in both the Tri gene transcript levels and the farnesyl 
pyrophosphate pool, as a result of the parallel inhibition of Fpps and other 
isoprenoid genes (described below), could be sufficient to prevent T-2 toxin 
production in the ∆Tri10 strain.  These possibilities can be addressed by future 
experiments.   
 
 
 
Tri5, Tri4 
Tri101 
Other Tri cluster
and 
non cluster 
Tri6 Tri10 
T-2 toxin 
Self Protection 
? 
? 
? 
?
Fpps 
?
?
?
  FIG. 2-7.  Proposed regulatory model for trichothecene biosynthesis.  Solid arrows indicate
known positive activators.  Dotted arrows indicate possible activation activities. Blocked
arrows indicate known inhibitory activities and dotted blocked arrows indicate possible
inhibitory activities.  Question marks indicate other hypothesized but unknown regulatory
signals or factors. 
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As shown in the model in Fig. 2-7, this study provides evidence for a 
regulatory circuit that links the primary and secondary metabolic pathways 
involved in trichothecene production by the coordinate regulation of transcript 
levels for these pathway enzymes.  A deletion of either Tri10 or Tri6 causes a 
severe reduction in Fpps transcripts, while overexpression of Tri10 causes an 
increase.  Based on additional work with our cDNA library (A. W. Peplow, A. G. 
Tag, G. Garifullina and M. Beremand, in press), EST database (Fusarium 
sporotrichioides Sequencing Project, B. A. Roe, Q. Ren, D. Kupfer, Hong-Shing 
Lai, M. Beremand, A. Peplow, and A. Tag 
[http://www.genome.ou.edu/fsporo.html]) and cDNA microarray studies (A. G. 
Tag, A. W. Peplow, T. -F. Hsieh, T. L. Thomas, and M. N. Beremand, 
unpublished), we have determined that this regulation extends to other genes in 
the isoprenoid biosynthetic pathway.  We are currently investigating the 
underlying regulatory mechanisms that mediate this control. 
 
The regulatory relationship between Tri10 and Tri6 appears to be further 
linked.  The elevation of Tri10 transcripts in the Tri6 deletion strain compared to 
the wild-type strain raises the interesting possibility of a regulatory loop whereby 
activation of Tri10 upregulates Tri6 transcription and the activation of Tri6 in turn 
directly or indirectly downregulates Tri10 transcription.  However, there must 
also be an independent mechanism which turns off Tri10 gene expression, 
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otherwise the Tri10 transcript levels would be constitutive in the Tri6 deletion 
strain. 
 
The regulation of Tri10 and toxin production is also controlled by a 
regulatory region upstream of Tri10.  In this study we show that homologous 
integration of pTri10-1 upstream of Tri10 increased trichothecene toxin 
production and Tri10, Tri6, Tri5, Tri4, Tri101, and Fpps gene expression.  This 
integration event produced a break in the Tri gene cluster approximately 700 bp 
upstream of Tri10 at the very end of the Tri5 amino acid-coding region.  We 
have conducted additional experiments which have revealed that this coordinate 
increase in toxin production and gene expression is defined by a regulatory 
region which extends upstream of the Tri10 coding region to the Tri5 promoter 
region and that overproduction can be caused by the disruption of this 
contiguous sequence (G. Garifullina, A. Tag, A. Peplow and M. Beremand, 
unpublished) (20).  These data suggest that the overproduction phenotype is 
due to the interruption of a cluster regulatory region that normally downregulates 
Tri10 gene expression.  This downregulation could be mediated in part through 
the Tri10-Tri6 regulatory loop proposed in the model above (Fig. 2-7) and further 
discussed below. 
 
Interestingly, both regulatory genes Tri6 and Tri10 flank the gene for the 
first biosynthetic step of the trichothecene pathway, Tri5, and this topography as 
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well as the direction of transcription is conserved in F. sambucinum (A.W. 
Peplow and M.N. Beremand, unpublished) and F. graminearum (17).  All three 
species also lack a TRI6 binding site (52) immediately upstream from Tri10, 
which is consistent with our data and the observation that the transcription of 
Tri10 is not dependent on TRI6 (this study).  Conversely, Tri10 is overexpressed 
in the ∆Tri6 strain, and notably, it contains a TRI6 binding site motif in the middle 
of its amino-acid coding region which could potentially be instrumental in 
mediating a reduction in Tri10 gene expression.  Although this internal binding 
site has not been shown to bind TRI6 in vitro (52), it could be utilized in vivo by 
TRI6 alone or associated with another inhibitory factor(s) to effectively block 
Tri10 gene expression.  It is also possible that the Tri6-dependent 
downregulation of Tri10 is directly associated with the downregulation of Tri10 
exerted by the regulatory region upstream of Tri10.  For example, the enhanced 
transcription of Tri5 by Tri6 may interfere with the transcription of Tri10.  
Chromatin remodeling could also be involved, independently or in conjunction 
with Tri6 activity.  However, regardless of the underlying mechanism(s) involved, 
the dependency of the wild-type regulation of Tri10 gene expression and toxin 
production on the DNA sequence extending upstream of Tri10 to in front of the 
Tri5 ORF suggests that the relative position of Tri5 and Tri10 may impose some 
evolutionary constraints on this region of the cluster such that it may be more 
stable than other regions within the cluster. 
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The regulatory controls exerted by Tri10 and imposed on Tri10 are 
complex and intimately intertwined, with Tri6 and cluster topography playing 
important roles.  As discussed above, these controls extend beyond the Tri gene 
cluster to a non-cluster Tri gene (Tri101) and to genes for primary metabolism.  
As discussed below, the expression of Tri10 and Tri6 also impact some aspects 
of trichothecene self-protection. 
 
While both Tri6, and to a lesser extent Tri10, are required for wild-type 
levels of T-2 toxin self-protection, the loss of self-protection in the ∆Tri6 and 
∆Tri10 strains is partial and dependent upon the culture conditions.  Thus, Tri6 
and Tri10 appear to play roles in self-protection which only become critical under 
certain conditions.  Tri6, and Tri10 via Tri6, may help to mediate the expression 
of one or more self-protection genes.  To date, two genes that potentially 
contribute to trichothecene self-protection have been identified:  Tri12, which is a 
major facilitator superfamily transporter gene located within the Tri gene cluster, 
and Tri101, which is a 3-o-acetyltransferase gene located outside of the Tri gene 
cluster.  Tri101 was first identified as a potential self-protection gene as it 
conferred trichothecene toxin resistance to otherwise toxin-sensitive yeast cells 
(64, 72).  However, additional genes for self-protection are likely in F. 
sporotrichioides since the deletion of Tri12 only partially decreased toxin self-
protection, and the deletion of Tri101 had no apparent effect on toxin sensitivity 
(4, 72).   
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Nonetheless, it is possible that Tri101 may contribute to self-protection 
under certain conditions, including those when other self-protection genes are 
repressed.  In this regard, it is interesting to note that even though Tri101 
displays what appears to be a background constitutive level of transcript 
accumulation in the ∆Tri10 and ∆Tri6 strains, the full expression of both Tri101 
(this study) and presumably Tri12, are dependent on the expression of both Tri6 
and Tri10.  Consequently, the increased sensitivity to T-2 toxin displayed by the 
∆Tri10 and ∆Tri6 strains could be due to the simultaneous reduction in the 
expression of both Tri12 and Tri101 as well as one or more additional genes that 
contribute to toxin self-protection. 
 
Finally, we also addressed whether the observed reduction in self-
protection in the ∆Tri10 and ∆Tri6 strains was due to an inability to make T-2 
toxin.  Examination of three different T-2 toxin minus mutant strains revealed 
that only the ∆Tri10 and ∆Tri6 strains and not the mutant unable to make a 
functional trichodiene oxygenase (Tri4-) displayed an increased sensitivity to T-2 
toxin.  Thus, the lack of T-2 toxin production itself does not lead to the reduction 
in self-protection, and consequently the expression of self-protection in F. 
sporotrichioides is not dependent upon the self-production of T-2 toxin. 
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The features of Tri10 strongly suggest a role as a regulatory gene in 
trichothecene biosynthesis.  The mRNA expression pattern of Tri10 is consistent 
with that of a regulatory gene.  The level of Tri10 transcript accumulation is low 
in wild-type cultures, and the transcripts appear before Tri6 transcripts in the 
Tri10 overproducing strain. Although Tri10 is highly conserved between F. 
sporotrichioides, F. graminearum, and F. sambucinum, only one other gene (an 
EST, function unknown) in GenBank had similarity to Tri10.  Likewise, a single 
motif, a putative transmembrane domain (amino acids 340-360), was identified 
within TRI10 (Simple Modular Architecture Research Tool) (91, 92).  Curiously, 
TRI10 is predicted to contain 16% leucine, but it does not contain any conserved 
motifs consistent with leucine repeats or zipper structures.  While the precise 
mode of action of TRI10 remains a mystery, its function is clear as an essential 
control point in trichothecene production and gene expression.  We are currently 
utilizing other molecular approaches in parallel with DNA microarrays to 
elucidate the function of Tri10 and further investigate the extent of the regulatory 
circuits defined by Tri10. 
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CHAPTER III 
 
 
A FUNCTIONAL GENOMICS APPROACH FOR EXPLORING FUNGAL 
SECONDARY METABOLISM:  TARGETED cDNA MICROARRAYS TO 
INVESTIGATE GENE EXPRESSION PROFILES ASSOCIATED WITH 
TRICHOTHECENE BIOSYNTHESIS 
 
 
INTRODUCTION 
 
The trichothecenes are toxic sesquiterpenoid compounds produced by 
fungi belonging to the genera Fusarium, Myrothecium, Trichoderma, 
Trichothecium and Stachybotrys (8, 60, 104).  These fungal secondary 
metabolites constitute one of the largest and most important groups of 
mycotoxins both scientifically and economically.  Since consumption of 
trichothecene-contaminated food and feed by humans and livestock can cause 
alimentary hemorrhage, emesis and immunosuppression (69)and because these 
mycotoxins can also function as virulence factors in plant-pathogen interactions 
(26, 85, 86), there is strong interest in obtaining information about the 
biosynthesis and genetics of trichothecene production in order to identify 
molecular targets that can be exploited to promote the development of methods 
which effectively reduce the synthesis of these compounds (81).  The 
identification and study of the regulatory genes and networks that control the 
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coordinate expression of the trichothecene genes therefore marks an important 
step in providing additional information and potential targets that can be used to 
help prevent mycotoxin contamination in crops. 
 
It is well established that trichothecenes are synthesized from the primary 
metabolite farnesyl pyrophosphate (FPP), a key product of the isoprenoid 
pathway and the shared precursor for sterol and terpene biosynthesis (Fig. 3-1).  
During trichothecene biosynthesis, FPP is cyclized to trichodiene (36).  
Trichodiene is then converted to T-2 toxin, the most predominant trichothecene 
produced by Fusarium sporotrichioides, via a biosynthetic pathway that includes 
14 additional steps (53).  More than a dozen genes dedicated to trichothecene 
biosynthesis have been isolated, and most have been found to be organized 
within a large, coordinately regulated gene cluster (17, 54, 65) (A. W. Peplow, A. 
G. Tag, G. Garifullina, and M. Beremand, in press). 
 
To date, two cluster-encoded regulatory genes, Tri6 (87) and Tri10 (96), 
have been shown to control the expression of trichothecene-specific genes.  Tri6 
encodes a Cys2-His2 zinc-finger DNA-binding protein which functions as a 
positive regulator of all the published Tri cluster genes (87, 96) (A. W. Peplow, 
A. G. Tag, G. Garifullina, and M. Beremand, in press) except for Tri10 (96) 
(Chapter II) (A. W. Peplow, A. G. Tag, G. Garifullina, and M. Beremand, in 
press); it also regulates the non-cluster Tri gene Tri101 (96).  Meanwhile, Tri10 
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FIG. 3-1.  Schematic diagram depicting the relationship of the isoprenoid, trichothecene, 
and other terpenoid biosynthetic pathways.  Enzymes represented by gene sequences 
on the targeted cDNA microarray are boxed.  Abbreviations:  ACAT, acetyl-CoA 
acetyltransferase, HMGS, hydroxymethylglutaryl-CoA synthase, HMGR, 
hydroxymethylglutaryl-CoA reductase, MK, mevalonate kinase, PMK, 
phosphomevalonate kinase, MPPD, mevalonate pyrophosphate decarboxylase, IPI, 
isopentenyl pyrophosphate isomerase, FPPS, farnesyl pyrophosphate synthetase. 
Dimethylallyl-PP 
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encodes a novel protein which acts upstream of Tri6 by a molecular mechanism 
which has not yet been defined (96). 
 
The regulation mediated by Tri10 and Tri6 also extends to genes involved 
in primary metabolism.  Previous work has shown that the expression of Tri10 
and Tri6 significantly influence the expression of four genes that encode 
biosynthetic enzymes in the isoprenoid biosynthetic pathway (acetyl CoA 
acetyltransferase, Acat; hydroxymethylglutaryl-CoA synthase, Hmgs; 
mevalonate kinase, Mk; and farnesyl pyrophosphate synthetase, Fpps) (96) (A. 
W. Peplow, A. G. Tag, G. Garifullina, and M. Beremand, in press).  Transcript 
levels for these genes are markedly reduced in the Tri10 and Tri6 deletion 
mutants but overexpressed when Tri10 is overexpressed.  Thus, Tri10 and Tri6 
control a regulatory network linking primary and secondary metabolism, but the 
full scope of this regulatory network remains to be determined.   
 
Current data also indicate that Tri10 and Tri6 form a regulatory loop 
whereby the expression of Tri10 positively regulates the expression of Tri6 and 
the expression of Tri6 negatively regulates the expression of Tri10 (96).  In turn, 
the expression of Tri10 is modulated by the disruption of DNA sequences 
upstream of Tri10 which results in its overexpression (96) (G. Garifullina, A. G. 
Tag, A. W. Peplow, and M. Beremand, unpublished data) and by a signal 
transduction pathway associated with the alpha subunit of a heterotrimeric G-
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protein (A. G. Tag, M. Beremand, unpublished results).  However, little else is 
known about the parameters that directly affect Tri10 gene expression. 
 
In this study, cDNA microarrays and additional strains with modified Tri10 
gene constructs were simultaneously employed to (1) gain further knowledge 
about the regulatory controls that Tri10 exerts and is subject to during 
trichothecene production and (2) to better understand the regulatory network(s) 
connecting the trichothecene-related primary and secondary metabolic 
pathways.  DNA microarray technology affords a global view of gene expression 
by allowing the rapid, parallel assessment of the relative changes in the 
expression of large populations of genes or specifically selected groups of genes 
(22, 32, 33, 56, 90).  This ability makes it an exceptionally useful tool for 
advancing the study of secondary metabolism in filamentous fungi.  Thus, one 
main goal was to produce and evaluate the capabilities of a targeted cDNA 
microarray with the dual purpose of obtaining new information about the 
regulation of the expression of genes involved in trichothecene biosynthesis and 
to serve as a platform for developing microarray technology for use with 
Fusarium.  
 
This study reports the characterization of F. sporotrichioides 
transformants expressing Tri10 under the control of an exogenous promoter and 
the development and utilization of a targeted cDNA microarray designed 
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specifically to monitor the transcription profiles for the primary and secondary 
metabolic genes associated with T-2 toxin production. 
  
MATERIALS AND METHODS 
 
Strains and culture conditions 
 
The wild-type F. sporotrichioides Sherb. strain NRRL 3299 (10), and the 
derived hygromycin-resistant Tri10 transformant strains FsTri10-1-12 (∆Tri10) 
and FsTri10-1-20 (?Tri10) (96) have been described previously.  Strains were 
both maintained on V8-juice agar slants (containing 300 µg/ml hygromycin B for 
transformants) and preserved at -70°C as conidial glycerol stocks (88).  Shake 
cultures for RNA and T-2 toxin analyses were prepared by inoculating 100 ml or 
25 ml, respectively, YEPD-5G medium (5% glucose, 0.1% yeast extract, and 
0.1% peptone) to a concentration of 5 X 104 conidia/ml from 7-d V8 juice agar 
plates and were grown at 28°C and 200 rpm.  Mycelia were collected by filtration 
and freeze-dried for RNA isolation (97).  Whole culture samples were stored at -
20°C for toxin studies.  Growth conditions for cultures for DNA isolation have 
been reported (88, 97). 
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Construction of pTri10-2 (pTAG15) and transformation of NRRL 3299 
 
The Tri10 overexpression plasmid pTri10-2 was constructed using pCL5 
(110), which contains both a 1.4-kb fragment of the promoter for the 
glyceraldehyde 3-phosphate dehydrogenase gene from Trichoderma virens and 
a hygromycin B resistance cassette (103).  The plasmid pCL5 was digested with 
Hind III to remove the existing insert downstream of the Gpd promoter.  The 
remaining plasmid backbone was gel-purified and ligated to the Tri10 open 
reading frame (ORF), which was amplified by PCR from NRRL 3299 genomic 
DNA using Pfu DNA polymerase and the primers A-26 (5’ 
tgaagcttaccacgcaaactcatcaatcgcagtcacaaatcagctacaatggaatttccgaagccg 3’) and 
A-27 (5’ gcaagcttcagcacagctggttggatctac 3’).  Both primers possess Hind III sites 
in their 5’ termini; the resulting PCR product was digested with Hind III and gel 
purified prior to ligation to the pCL5 backbone.  Primer A-26 also contains a 
fusion sequence joining the 3’ end of the Gpd promoter to the Tri10 ORF.  
Production and transformation of fungal protoplasts was performed as previously 
described (88, 97).  Transformants were isolated by selection on hygromycin B-
containing media (97) and screened by Southern hybridization and PCR using 
standard protocols (89). 
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Nucleic acid isolation/manipulation 
 
Fusarium genomic DNA and total RNA were isolated from freeze-dried 
mycelia according to previously described methods (97).  Polyadenylated mRNA 
was purified from total RNA with the Oligotex mRNA mini kit (Qiagen).   
 
T-2 toxin extraction and quantitation 
 
Cultures for toxin analysis were grown in YEPD-5 for 7 d and extracted 
with ethyl acetate as previously described (97).  Quantitation of T-2 toxin was 
performed by gas chromatography-mass spectrometry as reported previously 
(97) except that the mass selective detector was used in either ion-selective 
mode (for T-2 toxin quantitation) or full-scan mode (to obtain full spectrum).  T-2 
toxin was identified based on retention times and spectra compared to those of 
standards.  T-2 toxin was purchased from Sigma Chemical Co. (St. Louis, Mo.) 
and used without further purification.  Toxin levels of transformants were 
compared to the wild type by ANOVA using the JMP4 statistical software 
package. 
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cDNA sequencing and gene identification 
 
cDNA clones were obtained from a cDNA library which had been 
constructed using RNA isolated from the Tri10 overproducing strain (↑Tri10) 
grown under conditions favorable for trichothecene gene expression (A. W. 
Peplow, A. G. Tag, G. Garifullina, and M. Beremand, in press).  Clones selected 
for use in microarray analyses were chosen based either on sequence and 
hybridization data obtained in our laboratory or on sequence data generated for 
the first publicly released Fusarium cDNA sequencing project 
(http://www.genome.ou.edu/fsporo.html), which was conducted in collaboration 
with Dr. Bruce Roe and co-workers.  Functions assigned to genes other than the 
published trichothecene genes are based solely on sequence similarity to genes 
present in GenBank (Table 3-1).   
 
cDNA microarray construction and analysis 
 
DNA microarrays were constructed following procedures provided by the 
MGuide at http://cmgm.stanford.edu/pbrown/mguide/index.html.  PCR products 
were generated from the cDNA clones listed in Table 3-1 using T3 and T7 
primers.  A small aliquot of PCR product from each clone was subjected to 
agarose gel electrophoresis to ensure that only a single band was present and 
the remainder of the reaction was purified through a Qiaquick column (Qiagen).  
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20X SSC was added to each purified PCR product to give a final concentration 
of 3X SSC before being spotted in triplicate on poly-L-lysine-coated microscope 
slides (Sigma) by an OmniGrid Arrayer (GeneMachines, San Carlos, CA).  
Printed slides were UV crosslinked with 200 mJ energy in a Stratalinker 
(Stratagene) and processed in blocking solution (70 mM succinic anhydride, 0.1 
M sodium borate, pH 8 in 90% 1-methyl-2-pyrrolidinone).  Relative mRNA 
expression levels were measured via two-color parallel hybridization using Cy-3-
dUTP and Cy-5-dUTP labeled cDNA probes.  Fluorescently-labeled cDNA 
probes were prepared from approximately 200 ng poly(A) RNA using an oligo-
dT(11-18) primer 
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TABLE 3-1. cDNA clones used in targeted cDNA microarray construction. 
Gene Clone ID BLASTX  
Score 
BLASTX Homology 
Tri1 a3e02 311 5e-84 AAK77933.1 p450 monooxygenase [F. sporotric... 
Tri3 h1f12 141 6e-48 AY102604 trichothecene 15-O-acetyltransferase 
Tri4 a2e03 369 1e-101 AF359360_5 cytochrome P450 [Fusarium sporotrichioides] 
Tri5 a2c08 390 1e-107 P13513 Trichodiene synthase 
Tri6 pAWP70a  AAD11963 trichothecene biosynthesis transcription factor 
Tri7 s3b08 246 2e-64 AAK33076.1 Tri7 [Fusarium sporotrichioi... 
Tri9 h3d09 89 5e-17 AAK33078.1 Tri9 [Fusarium sporotrichio... 
Tri10 r1g06 328 4e-89 AAK53383.1 trichothecene biosynthesis regulator Tri10 
Tri11 i2a09 282 4e-75 AAD12755.1 isotrichodermin C-15 hydroxylase 
Tri12 t1d12 293 1e-83 AAK33071.1 trichothecene efflux pump 
Tri13 c1b10 226 1e-58 AAK15528.1 Tri13 [Fusarium sporotrichio... 
Tri14  h1f04 211 5e-82 AAG46054.1 Tri14 [Fusarium sporotrichio 
Tri15 j1b02 296 2e-80 AF327521 Tri15 [Fusarium sporotrichioides] 
Ibt6 i2d03 177 1e-43 AAC03053.1 lysophospholipase [Neurospora crassa] 
Ibt7 o1d10  No BLAST match 
Ibt1 e3d06 81 1e-14 BAC00848.1 Aspartic protease 
Ibt2 q3d11  No BLAST match 
Ibt4 i3c03  No BLAST match 
Tri101 m3b07 180 1e-44 AAK77937.1 trichothecene 3-O-acetyltransferase 
Pyruvate kinase a3e11b 144 2e-34 P31865 Pyruvate kinase   
Dhat a2g03b 104 2e-22 P20285 Dihydrolipoamide acetyltransferase   
Acat s4d11 207 6e-53 NP_596686.1 acetyl-coa acetyltransferase 
Hmgs p1e11 268 4e-71 T49718 probable hydroxymethylglutaryl-CoA synthase 
Mk a4e12b 75 1e-12 CAC28692.1 related to mevalonate kinase [Neurosp... 
Pmk a1e02b 75 2e-13 S57588 Phosphomevalonate kinase  
Fpps h4c06 192 2e-48 Q92235 Farnesyl pyrophosphate synthetase 
Citrate synthetase a2h08b 132 7e-31 AJ296102 mitochondrial citrate synthase   
Aconitate hydratase a3g12b 231 9e-61 AF093142 aconitase   
Isocitrate dehydrogenase a1g04b 248 1e-65 AY040207 l NADP-dependant isocitrate dehydrogenase 
Ibs1 a2d01 160 2e-38 NP_595868.1 putative nadh-dependent flavin oxidoreductase 
ADP/ATP carrier protein d1c01 242 4e-63 P02723 ADP,ATP carrier protein 
Cytochrome P450 a1g10b 55 2e-7 AAF26280.1 Cytochrome P450 monooxygenase   
Alcohol dehydrogenase i1f08 223 4e-57 Q9P6C8 Alcohol dehydrogenase I 
rAsp f9 j2a04 136 3e-31 AJ223327 rAsp f 9 
Potassium channel protein a1e03 200 2e-50 NP_588516.1 putative potassium channel subunit 
ABC transporter e2d03 93 2e-18 NP_013052.1 Yeast bile transporter, similar to mammalian Ybt1p 
Transcription factor r3c10 74 1e-12 CAC14775.1 putative transcription factor [Cladosporium fulvum] 
FadA pJY8c  G-protein, alpha subunit E. nidulans 
Core II protein d4d09 183 3e-49 CAD21046.1 ubiquinol-cytochrome c reductase complex core pro2 
Stress protein p3d12b 78 4e-14 AF352018 mold-specific protein MS95 [Ajellomyces capsulatus] 
RNA pol II large subunit j2a03 174 5e-43 AB017184  RNA polymerase II largest subunit 
EF 2 a2e09b 263 3e-70 AAK49353.1 Elongation factor 2   
Nucleosome assembly a2g05b 87 8e-17 NP_596230.1 Nucleosome assembly protein   
Histone H2A subunit s4c05 89 7e-29 AAL38970.1 histone H2A [Neurospora crassa] 
RNase F1/T1 p1f08 167 7e-47 BAA31984.1 ribonuclease F1 
Cell wall protein o2b02 52 5e-6 CAA64974.1 QI74 protein (cell wall protein) [T. harzianum] 
Actin a4e10 289 4e-78 O9UVW9 Actin, gamma 
9D4 i4b02  No BLAST match 
11K18 ki2f09  No BLAST match 
12M24 l2g12  No BLAST match 
18I12 r2e06  No BLAST match 
BLASTX searches were conducted using the BLASTX 2.2.1 algorhythm (6)and the 18-June-2002 release of the 
GenBank non-redundant database. 
aNo Tri6 clones were identified in the cDNA library, thus a plasmid containing the genomic DNA sequence of Tri6 was 
used to obtain the Tri6 amplimer for the microarray.  bIdentified through the Fusarium EST sequencing project.  All other 
clones were identified using sequence data obtained in our laboratory.  cThe pJY8 plasmid contains the fadAG42R DNA 
sequence of FadA from E. nidulans. (97) 
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and the Superscript Preamplification kit (Life Technologies).  Hybridizations were 
conducted at 62°C for 15 h in 2.5X SSC, 0.2% SDS, and 0.6 µg/µl sheared 
salmon sperm DNA.  After hybridization, the slides were washed once in 2.5X 
SSC + 0.2% SDS at room temperature for 5 min. and twice in 0.1X SSC at 42°C 
for 5 min. each.  The slides were then scanned using a Scanarray3000 Biochip 
Analyzer (General Scanning, Watertown, Ma.) scanner at 10 nm per pixel 
resolution.  Scans were acquired as 16-bit TIFF images and were analyzed 
using the ScanAlyze software version 4.21, publicly available at 
http://rana.lbl.gov.  Cluster analysis of the data was performed using the Cluster 
(Version 2.11) and TreeView (Version 1.45) software also available at the same 
web address. 
 
RESULTS 
 
Previous studies demonstrated that the disruption of the region upstream 
of Tri10 caused overexpression of Tri10 and a corresponding increase in Tri 
gene expression and T-2 toxin production (13, 96).  However, the disruption did 
not alter the temporal onset of Tri gene expression, including the expression of 
Tri10 (96) (M. Beremand, unpublished data).  It also raised the possibility that 
the overexpression phenotype might be dependent upon a disruption in this 
region of the Tri gene cluster and/or the presence of the overexpressed Tri10 
gene in the Tri gene cluster.  The following experiments were designed to 
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address these issues and to further investigate how the expression of Tri10 and 
its position in the genome, when under the control of a heterologous promoter, 
mediate the expression of the other Tri genes and T-2 toxin production.   
 
Placement of Tri10 under the control of a heterologous promoter 
 
The required experimental strains were generated by transforming F. 
sporotrichioides strain NRRL 3299 with plasmid pTRI10-2, which contains the 
Tri10 coding region fused to the glyceraldehyde 3-phosphate dehydrogenase 
(Gpd) promoter from Trichoderma virens.  Transformants that arose by either a 
homologous or ectopic single-site, single-copy integration event were identified 
by Southern blotting and hybridization (data not shown).  While both types of 
integration events produced transformants that carry a duplication of the Tri10 
gene with one copy regulated by the native Tri10 promoter and the second copy 
regulated by the Gpd promoter, only homologous integration events placed both 
copies of Tri10 in the Tri gene cluster (Fig. 3-2).   
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Figure 3-2.  Integration of the pTri10-2 plasmid.  Schemes of (A) homologous or (B) 
ectopic integration of the Gpd::Tri10 plasmid pTri10-2.  Panel A indicates the tandem 
arrangement of the two copies of Tri10 within the Tri gene cluster as a result of 
homologous integration of one copy of pTri10-2.  The resulting upstream copy of Tri10 
retains the wild type promoter and the downstream copy of Tri10 carries the Gpd 
promoter.  Panel B indicates the retention of the wild-type copy of Tri10 within the Tri 
gene cluster and the placement of the second Gpd promoter-driven copy of Tri10 at a 
separate genomic location. 
 66
Several transformants that arose from homologous integrations were 
obtained, and from these, isolate FsTri10-2-49 (Gpd::Tri10h) was chosen as a 
representative strain.  Two representative transformants, FsTri10-2-16 
(Gpd::Tri10e1) and FsTri10-2-24 (Gpd::Tri10e2), which arose by ectopic 
integration of the pTri10-2 vector, were also selected for further study.  Analysis 
of these three transformants by PCR utilizing primers within the Gpd promoter 
and the 3'-end of the Tri10 gene confirmed that the Tri10 gene was still 
physically downstream of the Gpd promoter after integration of the pTri10-2 
vector (data not shown).  Introduction of the heterologous promoter-driven copy 
of Tri10 now allowed us to examine what happens when Tri10 is overexpressed 
from a cluster-dependent or -independent position under conditions that alter its 
temporal expression and remove it from the native control imposed by the 
endogenous Tri10 promoter. 
 
Expression of Tri10 via a heterologous promoter results in overexpression 
of trichothecene genes and overproduction of T-2 toxin 
 
Northern analysis revealed that in comparison to the wild-type strain at 23 
h and 48 h, all three Gpd::Tri10 transformants exhibited increased expression of 
all the Tri cluster (Tri10, Tri6, Tri5, Tri4, Tri3), and noncluster (Tri101) genes 
examined (Fig. 3-3).  The most dramatic increases were observed for Tri10 and 
Tri3.  Also, unlike the wild-type parent strain, all three transformants  
 67
 
  Figure 3-3.  Northern analysis of Gpd::Tri10 transformants.  Northern blot analysis of the 
expression of Tri10, Tri6, Tri5, Tri4, Tri3, and Tri101 transcripts in wild-type (NRRL 3299), 
Gpd::Tri10h (FsTri10-2-49), Gpd::Tri10e1 (FsTri10-2-16), and Gpd::Tri10e2 (FsTri10-2-24) 
strains of F. sporotrichioides grown in parallel for 15, 23, and 48 h.  5 µg of total RNA was 
loaded per lane.  32P-labeled probes for each gene were prepared and hybridized as 
described in the Material and Methods.  Ribosomal RNAs were visualized in the gel by 
ethidium bromide staining. 
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expressed the Tri10 gene at 15 h.  Thus, in all three transformants, the 
placement of Tri10 under the control of the Gpd promoter consistently lead to an 
overexpression of Tri10 and the other Tri genes at 23 h and 48 h, accompanied 
by some level of Tri10 overexpression at 15 h, independent of whether the 
Gpd::Tri10 gene construct was positioned inside or outside of the Tri gene 
cluster. 
 
However, it is important to note that each transformant also displayed a 
unique transcript profile at the 15 h time point.  At 15 h, even though the ectopic 
transformant, Gpd::Tri10e2, and the homologous transformant, Gpd::Tri10h, both 
exhibited a similar Tri10 transcript accumulation level and the other ectopic 
transformant, Gpd::Tri10e1, actually exhibited a much higher Tri10 transcript 
level, only the ectopic strain Gpd::Tri10e2 also simultaneously expressed the 
other cluster-encoded Tri genes; the remaining two transformants both retained 
an otherwise wild-type parent transcript profile. 
 
An examination of T-2 toxin levels demonstrated that the increased Tri 
gene transcript accumulation observed in the Gpd::Tri10 transformants was 
accompanied by an increase in T-2 toxin production.  In fact, transformants 
arising from either homologous or ectopic integration of the Gpd promoter-driven 
copy of Tri10 displayed a significant increase in T-2 toxin production in 
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comparison not only to the wild-type strain, but also to the previously described 
Tri10 overproducing strain, FsTri10-1-20 (↑Tri10) (Table 3-2). 
 
 
TABLE 3-2.  Production of T-2 toxin by pTri10-2 transformants. 
__________________________________________________________ 
 
Classa  Strain     µg/ml T-2 toxinb 
__________________________________________________________ 
Gpd  FsTri10-2-16 (Gpd::Tri10e1) 3002±370 
 
Gpd  FsTri10-2-24 (Gpd::Tri10e2) 2899±139 
 
Gpd  FsTri10-2-49 (Gpd::Tri10h)  2440±218 
 
↑Tri10  FsTri10-1-20    704±102 
 
Wild-type NRRL 3299    368±22 
__________________________________________________________ 
a The Gpd and ↑Tri10 class transformants were each found to be significantly  
different from the wild-type strain and from each other regardless of the type of  
integration by ANOVA. 
bValues shown represent the mean of individual extractions of triplicate cultures. 
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Targeted cDNA microarray data parallel Northern data 
 
The following experiment was conducted in order to examine and thereby 
validate the utility of targeted cDNA microarrays to accurately assess gene 
transcript profiles.  The criteria were the ability of the targeted cDNA microarray 
to discern the known coordinate regulation of the Tri genes by Tri10 and to 
determine which, if any, additional genes were also most similarly affected by 
Tri10 gene expression.  Accordingly, fluorescently labeled cDNA samples 
derived from 23 h cultures of two Tri10 transformants, FsTri10-1-12 (∆Tri10) and 
FsTri10-1-20 (↑Tri10), were hybridized to separate targeted cDNA microarrays 
using labeled wild-type 23 h cDNA as a reference sample, and the resulting data 
collected from these initial hybridizations were subjected to hierarchical 
clustering by Cluster software (Vers. 2.11).   
 
As seen in Fig. 3-4A, the above analysis revealed a group of 21 genes 
that displayed very similar expression patterns with regard to the expression of 
Tri10.  When Tri10 was disrupted these genes were negatively influenced, and 
when Tri10 was overexpressed they were slightly overexpressed.  Significantly, 
this group included 14 of the 17 tested Tri genes, four genes involved in the 
isoprenoid pathway leading into trichothecene biosynthesis, one gene involved 
in the citric acid cycle, and two genes not obviously linked to trichothecene 
biosynthesis (Fig 3-4A+).  These data are consistent with our previous studies  
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  FIG. 3-4.  Cluster analysis from targeted cDNA microarrays.  Cluster diagrams from targeted microarray analysis of 
gene expression for wild-type (wt), Tri10-deficient (∆Tri10), and Tri10-overexpressing (↑Tri10) strains, and Gpd-driven 
Tri10-overexpressing strains arising from homologous (Gpd::Tri10h) or ectopic (Gpd::Tri10e1, Gpd::Tri10e2) integration of 
the pTri10-2 vector.  Red blocks indicate overexpression in comparison to the wild-type strain at 23 h and green blocks 
indicate lower expression levels than the wild-type strain at 23 h.  Grey blocks indicate missing or poor data.  Blue dots 
represent Tri genes, yellow dots represent trichothecene regulators, and magenta dots represent primary metabolic 
genes in pathways upstream of trichothecene biosynthesis.  (A) Cluster analysis of 23-h ∆Tri10 and ↑Tri10 strains 
compared with wild type.  (B) Comparison of gene expression profiles for the wild-type strain and Tri10 transformants 
over time.  Numerical data are provided in Appendix A. 
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 (96) (A. W. Peplow, A. G. Tag, G. Garifullina, and M. Beremand, in press) 
based on Northern and DNA macroarray analyses.  Consequently, they not only 
further substantiate that the expression of Tri10 coregulates the Tri genes and 
these four isoprenoid genes as determined by the examination of the ∆Tri10 and 
↑Tri10 strains at 23 h, but they also validate the usefulness and accuracy of the 
targeted cDNA microarrays.   
 
In addition, the two regulatory genes, Tri10 and Tri6, are clustered 
together independently of the other Tri genes (Fig. 3-4A).  This result indicates 
that these microarrays are also able to separate the trichothecene biosynthetic 
and regulatory genes into biologically significant groups. 
 
Refinement of hierarchically clustered genes by additional cDNA 
microarray analysis 
 
In microarray analysis, the power of resolving a large group of genes into 
informative subgroups can be magnified by meaningfully increasing the number 
of conditions or experimental parameters.  Time and mutation are two such 
parameters.  For several of the Tri genes, it has been shown that when the F. 
sporotrichioides NRRL 3299 strain is growing in liquid shake culture, the 
maximum transcript accumulation level is reached near 23 h post-inoculation 
and then declines (87, 96).  Therefore, in the following experiments the 
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transcription profiles for the known Tri genes were examined over time by 
comparing 48-h or 60-h RNA to 23-h wild-type RNA.  The FsTri10-2 
transformant strains were also examined to further assess the influence of Tri10 
on gene expression when Tri10 is expressed via a heterologous promoter.  As 
seen in Fig. 3-4A, the cDNA microarray experiments included comparisons 
between Gpd::Tri10h, Gpd::Tri10e2, ↑Tri10 and wild-type strains at selected time 
points using 23-h wild-type RNA as a reference sample.  Hierarchical clustering 
of the data from these microarrays revealed that 14 of the 21 genes shown to be 
influenced by Tri10 in the previous microarray analysis (Fig. 4A), continue to 
cluster (Fig. 4B+).  These 14 genes include 11 Tri genes and three isoprenoid 
biosynthetic genes.  The remaining seven genes included one isoprenoid gene 
(Mk) and four Tri genes:  Tri5, the first biosynthetic gene in the trichothecene 
pathway, and three genes with uncharacterized function, Ibt1, Ibt2 and Ibt4).  Of 
these four genes, only Ibt1 and Ibt4 cluster together.  Notably, Tri6 and Tri10 are 
still tightly grouped together and again fall outside of any group containing other 
Tri genes.  There was also a small group of co-clustered genes whose 
expression was affected by both time and a general negative influence by Tri10 
overexpression; this group includes a putative histone protein, RNase, and cell 
wall protein (Fig. 3-4B-).  Finally, based on an overall view of the gene transcript 
profiles as depicted in Fig. 3-4B, it is readily apparent that the Tri gene 
transcripts are present in the three Tri10 upregulated strains at 48 h and 60 h 
compared to a corresponding decline in these transcripts in the wild-type strain 
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at these same time points.  This is consistent with all of our Northern analyses 
conducted for these transformants.   
 
DISCUSSION 
 
This study has demonstrated the successful application of cDNA 
microarray technology in the investigation of gene regulation specifically related 
to secondary metabolism in filamentous fungi.  The coupling of this technology 
with the ability to produce genetically engineered mutants altered in 
trichothecene biosynthesis has provided a fresh approach to unravel the 
complex details governing the regulation of secondary metabolism.  It has 
further afforded new opportunities to investigate the regulatory networks linking 
primary and secondary metabolism.  In this study the analysis of Tri10 gene 
expression directed by an exogenous promoter has expanded our 
understanding of how Tri10 gene expression simultaneously affects the 
expression of the other Tri genes, selected isoprenoid genes and T-2 toxin 
production. 
 
The data presented in this study definitively establish that the 
overexpression of Tri10 in an otherwise wild-type background is sufficient to 
promote the overexpression of Tri6 and the other Tri genes examined.  In 
previous studies, the overproduction of the Tri10 gene was produced by 
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disrupting the DNA region upstream of Tri10 with an inserted DNA fragment, 
which raised the possibility that either the disruption itself and/or the presence of 
the overexpressed Tri10 gene in the Tri gene cluster were essential for the 
resulting phenotype (96) (G. Garifullina, A. G. Tag, A. W. Peplow, and M. 
Beremand, unpublished data).  However, in the present study, the ability of a 
Gpd-promoter driven copy of Tri10-- whether integrated within or outside of the 
Tri gene cluster--to promote the overexpression of Tri10 and the other Tri genes 
eliminated these possibilities.  In fact, the overexpression and overproduction 
phenotype exhibited by the Gpd::Tri10 transformants is greater than the 
phenotype observed in the ↑Tri10 strain.  A comparison of the amount of T-2 
toxin accumulated by 7-d cultures revealed that toxin levels for the above 
Gpd::Tri10 transformants were four times higher than for the ↑Tri10 strain and 
approximately seven-to-eight times higher than for the wild-type parent strain, 
independent of the integration site of the Gpd::Tri10 vector.   
 
Since the Tri cluster genes are not normally expressed in liquid culture 
prior to 18 h post-inoculation, the placement of Tri10 under the control of the 
Gpd promoter was also designed to test (1) if the early expression of Tri10 was 
sufficient to activate the early expression of the other Tri genes and (2) if the 
early expression of Tri10 from a location within or outside the Tri gene cluster 
would influence either the level of Tri10 gene expression and/or the ability of 
Tri10 to activate the early expression of the other Tri genes.  The current data 
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did not provide a simple answer.  A comparison of the data from the homologous 
transformant, Gpd::Tri10h, and the ectopic transformant, Gpd::Tri10e1, alone 
would indicate that Tri10 is more highly expressed at 15 h when the Gpd::Tri10 
gene construct is located outside of the Tri gene cluster, but that the co-
activation of the expression of the other Tri cluster genes does not occur at 15 h 
in either case.  On the other hand, a comparison of the data from the 
homologous transformant with the other ectopic transformant, Gpd::Tri10e2, 
would suggest that the level of expression of Tri10 from the Gpd promoter is the 
same at 15 h whether the gene construct is inside or outside of the Tri gene 
cluster, but that only an ectopic copy could also stimulate the expression of the 
other Tri genes at 15 h.  Thus, the transcription profiles for two of the 
transformants, Gpd::Tri10h and Gpd::Tri10e1, suggests that the early increased 
transcription of Tri10 is not sufficient to elicit the early transcription of the other 
Tri genes while the transcription profile for the third transformant, Gpd::Tri10e2, 
suggests that it is sufficient.  At present, it is not known why the other Tri cluster 
genes were expressed at 15 h only in Gpd::Tri10e2.  However, the above results 
do demonstrate that the early expression of Tri10 does not guarantee the co-
activation of the other Tri genes, but that it is also clearly possible to express this 
group of genes earlier than when it occurs in the wild-type parent.  Further 
clarification of the critical factors that allow this temporal change in gene 
expression will require additional experiments. 
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It is now well established that DNA microarrays can provide a powerful 
tool for functional genomic studies by revealing the coordinated patterns of gene 
expression that mirror the genetic regulatory networks and biosynthetic 
pathways that direct the cellular metabolism of an organism (32, 33, 56, 82).  
Data obtained from the targeted cDNA microarrays simultaneously confirmed 
our previous studies, conducted using both Northern analyses and DNA 
macroarrays, and validated the application of this technology to our experimental 
system.  As discussed below, the co-clustering of genes, both of known and 
unknown function, by shared transcription profiles on the targeted cDNA arrays 
has also extended our previous studies. 
 
Microarray analysis of the ∆Tri10 and ↑Tri10 strains, using a single time 
point of 23 h with the wild-type RNA from 23 h as a reference sample, clustered 
the two trichothecene regulatory genes, Tri10 and Tri6, apart from a group of 
genes that are strongly influenced by Tri10 expression.  Not unexpectedly, this 
latter group includes Tri genes from both within and outside of the Tri gene 
cluster.  Also present in this group are four primary metabolic genes from the 
isoprenoid pathway (Acat, Hmgs, Mk, and Fpps).  These data are consistent 
with previous findings and provides further evidence for a regulatory circuit 
linking the primary and secondary metabolic pathways involved in trichothecene 
biosynthesis.  Most important, is the presence of two other genes in this group:  
Ibt6 (Influenced by ten), which is a possible lysophospholipase, and 9D4, a gene 
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of unknown function.  Significantly, Ibt6 was previously identified in a differential 
screen as a gene regulated by Tri10 (A. W. Peplow, A. G. Tag, G. Garifullina, 
and M. Beremand, in press).  The potential relationship of both Ibt6 and 9D4 to 
trichothecene production is being investigated.  It is also noteworthy that the 
following three genes, which we might have expected to cluster within this 
group, failed to do so:  two genes recognized as being influence by Tri10 (Ibt7 
and Ibt2) and the isoprenoid biosynthetic pathway gene phosphomevalonate 
kinase (Pmk).  This suggests that these three genes are not as closely regulated 
by Tri10 as are the other Tri genes and the isoprenoid genes. 
 
The above defined groups were further resolved by increasing the 
number of experimental parameters known to affect Tri10 gene expression.  The 
Gpd::Tri10 strains were included in this study because of their much larger effect 
on Tri gene expression and toxin production.  Time was also incorporated as a 
variable because as time progresses from 23 h to 60 h post inoculation Tri gene 
expression generally decreases in the wild-type strain while it is maintained in 
the Tri10-overexpression strains.  Despite these increased constraints, three of 
the isoprenoid pathway genes (Acat, Hmgs, and Fpps) continued to co-cluster 
with the majority of the Tri genes.  Interestingly, these three genes fall at either 
the beginning or the end of the isoprenoid pathway (Fig. 3-1).  While the 
significance of this clustering remains to be determined, it suggests that the 
expression of these three isoprenoid genes represent key regulatory points in 
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relation to trichothecene production.  The resolving power of the targeted arrays 
was additionally illustrated by the fact that the two remaining isoprenoid genes, 
Mk and Pmk co-cluster with each other.  Notably, these two genes encode the 
enzymes which catalyze adjacent steps in the isoprenoid biosynthetic pathway 
(Fig. 3-1).  In the same manner, Tri5, which previous studies have shown is not 
as tightly regulated by Tri10 as are the other Tri genes, also clustered separately 
from the core group of Tri genes as did Ibt1 and Ibt4.  The co-clustering of these 
latter two genes further suggests that they share closely related functions; in fact 
we previously noted that both of these genes might encode pathogenicity factors 
(A. W. Peplow, A. G. Tag, G. Garifullina, and M. Beremand, in press).  Lastly, 
the tight clustering of the trichothecene regulatory genes Tri10 and Tri6 
demonstrates the ability of these targeted arrays to resolve genes into 
functionally significant groups.  Thus even these small targeted microarrays can 
be used effectively to detect subtle differences in transcript profiles as well as 
common trends.   
 
Certainly an analysis of the full genome should reveal a number of genes 
that are inversely influenced by Tri10 gene expression.  Even within the narrow 
scope of the genes selected for our targeted microarray, a number of co-
clustered genes that were downregulated when the Tri genes were upregulated 
were observed (Fig. 3-4B-).  This group includes genes with homology to histone 
H2A, RNase F1/T, and a cell-wall protein.  While the exact function of these 
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homologs in Fusarium is not known, it is tempting to speculate that the 
expression of the trichothecene genes is coordinated with chromatin remodeling, 
mediated in part by a reduction in H2A, and with increased RNA stability 
mediated by a reduction in a specific RNAse.  Additionally, increased toxin 
production also may demand alterations in cell wall composition.  Experiments 
are under way to investigate these possibilities and to determine if these genes 
may therefore represent important new targets for controlling trichothecene toxin 
production.   
 
While it is now quite evident that Tri10 plays a central role in the 
transcriptional regulation of genes not only for the trichothecene biosynthetic 
pathway but also for the isoprenoid pathway, its molecular mode of action 
remains a mystery.  However, BLAST searches of data from the first drafts of 
the Aspergillus fumigatus (The Institute for Genomic Research 
(http://www.tigr.org)) and Magnaporthe grisea (Magnaporthe Sequencing 
Project. Ralph Dean, Fungal Genomics Laboratory at North Carolina State 
University (http://www.fungalgenomics.ncsu.edu), and Whitehead Institute/MIT 
Center for Genome Research (www-genome.wi.mit.edu)) genome sequencing 
projects have identified genes with some similarity to Tri10 in these organisms.  
Analyses of these two genes may yield critical information that could suggest 
functional motifs which can be investigated by additional mutational studies.  It is 
also intriguing that the M. grisea Tri10 ortholog resides adjacent to the only 
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hydroxymethylglutaryl-coenzyme A reductase (Hmgr) gene for the isoprenoid 
biosynthetic pathway in that organism because we have recently determined 
that Tri10 regulates Hmgr expression in F. sporotrichioides (Chapter IV). 
 
The targeted cDNA microarrays will continue to serve a valuable function 
in future experiments.  At the same time, the ability to interrogate larger sets of 
genes will provide more information about the regulatory relationships between 
the primary and secondary metabolic pathways for trichothecene biosynthesis 
as well as about important regulatory networks involving signal transduction 
pathways which have been previously shown to affect Tri gene expression (97). 
It will be especially interesting to determine if Tri10 influences the expression of 
any of the genes from parallel FPP initiated metabolic pathways, including those 
for carotenoid, gibberellin, and ergosterol biosynthesis (Fig. 3-1).  Thus, 
information gained from the EST database 
(http://www.genome.ou.edu/fsporo.html) is being utilized to build expanded 
targeted arrays containing several hundred genes, and ultimately arrays that 
represent the unigene set defined by the above EST database will be 
constructed.  These arrays, in conjunction with additional genetically engineered 
and mutant strains, will provide increased knowledge regarding key aspects of 
functional genomics as they relate to secondary metabolism.  Such arrays will 
have an added utility in exploring plant-pathogen interactions including further 
investigation of the role(s) that secondary metabolism plays in the establishment 
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of important plant diseases.  All of these studies have the potential to reveal 
important new targets for controlling or preventing mycotoxin contamination. 
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 CHAPTER IV 
 
THE ISOPRENOID GENE HMGR IS REGULATED BY TRI10 
INDEPENDENTLY OF THE FLOW OF FARNESYL INTO THE 
TRICHOTHECENE BIOSYNTHETIC PATHWAY 
 
INTRODUCTION 
 
Fusarium species cause scab diseases of small grains.  In addition to 
causing reductions in yield, Fusarium species also contaminate the grain with 
trichothecene mycotoxins.  The trichothecenes are potent inhibitors of eukaryotic 
protein synthesis and cause hemorrhage, emesis, and immunosuppression in 
humans and animals that consume contaminated grains (69).  In addition to 
causing disease in animals, the trichothecenes have been shown to contribute to 
the virulence of specific Fusarium species on specific plant hosts (25, 27, 30, 
31).  Thus, efforts to prevent the destruction of small grains by Fusarium through 
preventing trichothecene production by the fungus would have the additional 
benefit of preventing exposure of humans and animals to trichothecenes. 
 
Two regulators controlling trichothecene biosynthesis have been isolated 
and characterized.  Both reside within the core trichothecene gene cluster.  Tri10 
encodes a regulator of unknown mechanism which is required for T-2 toxin 
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production and wild type expression of the trichothecene genes.  Tri6 encodes a 
zinc-finger DNA-binding protein also required for trichothecene production and 
wild type expression of the Tri genes.  A model of regulation for Tri gene 
expression in which Tri10 and Tri6 form a regulatory loop to account for the 
observation that Tri10 is required for wild type expression of Tri6, and Tri6 is 
required to limit the expression of Tri10 has been proposed (96).  The 
expression of Tri10 and Tri6 are also required for the wild type expression of 
several isoprenoid genes upstream from the trichothecene biosynthetic pathway:  
farnesyl pyrophosphate synthetase (Fpps), 3-hydroxyglutarylmethyl-CoA 
synthase (Hmgs), and acetyl-CoA acetyltransferase (Acat) (Chapter II)(A. W. 
Peplow, A. G. Tag, G. F. Garifullina, and M. N. Beremand, in press).  However, it 
was unclear whether the observed regulation of these primary metabolic genes 
by Tri10 and Tri6 was due to the change in the expression of Tri10 and Tri6 or 
due to the resulting changes in metabolite flow and/or T-2 toxin production 
caused by the disruption of each of these regulatory genes.  This study was 
designed to address these questions in order to better understand the means by 
which Tri10 regulates the expression of the genes in the isoprenoid 
(mevalonate) pathway. 
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MATERIALS AND METHODS 
 
Strains, culture conditions, and fungal transformation 
 
The Fusarium sporotrichioides wild-type strain NRRL 3299 was obtained 
from the ARS/USDA Culture Collection at the National Center for Agricultural 
Utilization and Research in Peoria, Ill.  The F. sporotrichioides strains MB5493 
(tri4) (10, 75), FsTri10-1-12 (∆tri10) and FsTri10-1-20 (↑Tri10) (96), and NN4 
(∆tri6) (87), have been described previously.  The tri5 point mutant strain, 
FsTri5-6, which has a G to T change in codon 30 and is thus a nonsense mutant 
allele of Tri5, was provided by G. Garifullina.  Stock cultures were routinely 
established from frozen glycerol stocks (-80°C) onto V8 juice agar slants either 
with (for transformants) or without (for the wild-type strain and the UV mutant) 
the addition of hygromycin B (300 µg/ml).  Transformation of FsTri5-6 was 
performed as described previously (88, 97) using pTri10-2 (Chapter III).  
Transformants were grown in the dark with an alternating temperature schedule 
of 12h 25°C/12h 20°C whereas all other strains were grown under conditions of 
alternating 12h light / 25°C and 12 h dark/20°C.  Liquid cultures for DNA, RNA 
and toxin analysis were inoculated and grown in YEPD-2G medium for DNA 
isolation and YEPD-5 medium for RNA and toxin analysis as previously 
described (88, 97). 
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Nucleic acid isolation and analysis 
Fungal genomic DNA isolation was performed as previously described 
(97).  Southern blots were prepared utilizing standard techniques (89).  Total 
RNA was isolated using the Ultraspec II kit (Biotecx, Houston, Tx) according to 
previously described methods (97).  For RNA blots, 5 µg of total RNA were 
loaded per lane on formaldehyde-containing 1% agarose gels, subjected to 
electrophoresis, and blotted onto Hybond N+ nylon membranes.  Northern 
hybridization probes were gel purified Apa I-Sma I restriction fragments of 
cDNAs corresponding to the genes of interest labeled with 32P-dCTP via nick 
translation.  The Hmgr clone (b4g02fs) used in this study was identified through 
the Fusarium cDNA sequencing project (University of Oklahoma, Bruce A. Roe, 
Qun Ren, Doris Kupfer, HongShing Lai, Marian Beremand, Andrew Peplow and 
Andrew Tag) by homology to other Hmgr genes.  Five prime and 3’ sequences 
of this clone have been deposited in GenBank under the accession numbers 
BI188105 and BI188106 respectively. 
 
Toxin analysis 
Cultures were extracted for trichothecenes using previously described 
procedures and analyzed for T-2 toxin by gas chromatography/mass 
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spectrometry (97).  T-2 toxin was identified by comparison to a commercial 
standard (Sigma) which was used without further purification. 
 
 
 
RESULTS 
 
A premature stop codon in Tri5 prevents T-2 toxin production 
 
Previous studies have indicated the presence of a regulatory region, 
extending upstream of Tri10 into the Tri5 promoter, that controls Tri10 gene 
expression and toxin production (G. Garifullina, A. Tag, A. Peplow, and M. 
Beremand, unpublished data)(Chapter II)(M. Beremand, unpublished data).  
Since any attempt to construct a tri5 mutant by deletion or disruption of the Tri5 
gene would interrupt this sequence and potentially alter the expression pattern 
of Tri10, our approach was to use a Tri5 point mutant strain that contained a 
premature stop codon.  The introduced stop codon in the Tri5 gene in strain 
FsTri5-6 (tri5-1) was confirmed by DNA sequence analysis.   
 
The analysis of liquid shake culture extracts by GC-MS revealed that the 
tri5-1 strain did not produce any T-2 toxin in comparison to the wild-type strain 
(Fig 4-1). 
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Introduction of a GPD promoter-driven copy of Tri10 into FsTri5-6 
 
Strain FsTri5-6 (tri5-1) was transformed with pTRI10-2 (Chapter III) which 
contains the coding region of Tri10 fused to the glyceraldehyde 3-phosphate 
dehydrogenase (Gpd) promoter from Trichoderma virens.  Twenty-five 
hygromycin resistant transformants were recovered and screened by Southern 
analysis to determine the site of integration.  All of the transformants recovered 
were the result of homologous integration of the pTRI10-2 vector into the Tri10 
locus (data not shown).  From these, transformants tri5-1/Gpd::Tri10-1, tri5-
1/Gpd::Tri10-3, tri5-1/Gpd::Tri10-8, and tri5-1/Gpd::Tri10-15 were selected for 
further study.  GC-MS analyses of liquid shake culture extracts from these 
transformants revealed that none produced T-2 toxin (Fig 4-1). 
 
Deletion of Tri10 and Tri6, but not the presence of biochemical blocks 
early in the trichothecene biosynthetic pathway, reduces Hmgr transcript 
levels 
 
Northern analysis revealed that the deletion of Tri10 and Tri6 resulted in a 
dramatic decrease in Hmgr transcript accumulation compared to wild-type in 
contrast to the tri5-1 strain which accumulated wild-type levels of Hmgr transcript 
(Fig 4-2).  This suggests that Tri10 and Tri6 are required for wild-type levels of 
Hmgr transcript accumulation during Tri gene expression and that flow of 
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farnesylpyrophosphate into the trichothecene biosynthetic pathway and T-2 toxin 
production are not responsible for the observed increased Hmgr expression. 
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b) tri5-1 
a) Wild-type 
Time (min.)
T-2 toxin
Ergosterol
c) tri5-1/Gpd::Tri10-1 
  FIG. 4-1.  GC-MS analysis of tri5-1 mutant strains.  Chromatograms 
produced from culture extracts of:  (a) Wild-type F. sporotrichioides NRRL 
3299, (b) the Tri5 point mutant (tri5-1) possessing a premature stop codon 
FsTri5*-6, and (c) tri5-1/Gpd::Tri10-1 which overexpresses Tri10 in the tri5-
1 mutant background.  The small amount of ergosterol seen in the tri5-1 
mutant is most likely mycelial contamination from the extraction process. 
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 Wild type Hmgr transcript levels were also observed in the tri4 mutant, 
providing further evidence that the lack of T-2 toxin production does not alter the 
transcription of this gene (Fig 4-3).  Similarly, the transcription of Hmgr does not 
appear to be altered by the accumulation of trichodiene since the tri4 strain is 
blocked in the second step of the trichothecene pathway and accumulates this 
pathway intermediate. 
 
Interestingly, there may be a slight increase in the transcript levels for 
Tri3, Tri4, Tri6, and Tri1 in the tri5-1 strain (Fig. 4-2).  It is conceivable that even 
the point mutation in the Tri5 gene sequence produced a slight Tri10 
overexpression phenotype.  However, this change did not produce a true Tri10 
overexpression phenotype because the transcript levels for Tri101 are actually 
decreased in the tri5-1 strain compared to the wild type parent strain.  Notably, 
the Tri101 transcript levels are also slightly reduced in the tri4 strain, while the 
transcript levels for Tri6 and Tri5 are similar to those in the wild-type parent. 
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Tri1 
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Wt tri5-1 
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Tri5 
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Tri3 
Wt tri5-1 
23 48 60 23 48 6023 48 60 23 48 60
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∆Tri6
23 48 60
∆Tri10
FIG 4-2.  Northern analysis of tri5-1 mutant strains.  
Northern analysis of Tri10, Tri5, Tri3, Tri101, Tri4, Tri1, 
Tri6, and Hmgr in wild-type F. sporotrichioides NRRL 3299 
and tri5-1, which contains a premature stop codon in the 
Tri5 gene.  Five micrograms of total RNA was loaded per 
lane.  Ribosomal RNAs were visualized by ethidium 
bromide staining. 
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Overexpression of Tri10 in tri5-1 via a heterologous promoter results in 
overexpression of trichothecene and isoprenoid pathway genes 
 
 An examination of Tri gene transcript accumulation in the tri5-
1/Gpd::Tri10 strains revealed a dramatic increase in the expression of both 
regulatory genes, Tri10 and Tri6, and the isoprenoid gene Hmgr at 15 h, 23 h 
and 48 h post-inoculation (Fig. 4-3).  The expression of Tri5 and Tri101 was also 
increased in the tri5-1/Gpd::Tri10 strains at 15 h compared to wild-type.  
Notably, these strains do not exhibit the same degree of overexpression of 
Tri101 transcripts at 23 h and 48 hr as observed for the other genes (with the 
exception of Tri5).  However, the evaluation of the levels of the Tri5 gene 
transcripts in these transformants must take into account the possible reduced 
stability of the Tri5 transcript since it carries a nonsense mutation. 
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Tri10 
Tri5 
Hmgr 
rRNA 
Tri6
Tri101 
rRNA 
15 23 4815 23 4815 23 48 15 23 4815 23 48 23 48 
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tri5-1/Gpd::Tri10 
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Wt tri4 #1 #3 #8 #1
tri5-1/Gpd::Tri10 
  FIG. 4-3.  Northern analysis of tri5-1/Gpd::Tri10 strains. 
Northern analysis of Tri10, Tri5, Tri6, Tri101 and Hmgr 
expression in wild-type F. sporotrichioides, a tri4 mutant 
(MB5493) which is blocked in the second step of the 
trichothecene pathway, and pTri10-2 transformants of tri5-1 
containing a copy of Tri10 under the control of the Gpd 
promoter from T. virens.  Five micrograms of total RNA was 
loaded per lane. 
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DISCUSSION 
 
 The present study provides compelling evidence that the regulatory link 
between trichothecene secondary metabolism and isoprenoid primary 
metabolism in F. sporotrichioides is mediated by the expression of Tri10 and 
Tri6.  Previously, studies had shown that 3 isoprenoid genes (Hmgs, Mk, Fpps) 
were influenced by the expression of Tri10 and Tri6 (96, 97) (A. W. Peplow, A. 
G. Tag, G. F. Garifullina, and M. N. Beremand, in press)(Chapter III, Fig. 3-4).  
However, in those studies it was unclear whether the changes observed in 
isoprenoid gene expression were directly due to the loss of Tri10 and Tri6 gene 
expression, the concomitant decline in the flow of farnesyl into the trichothecene 
biosynthetic pathway, or the resulting lack of T-2 toxin production.  In the present 
study, the metabolic flow of farnesyl into the trichothecene biosynthetic pathway 
and T-2 toxin production were prevented while preserving Tri10 and Tri6 gene 
expression.  This was accomplished by creating a Tri5 point mutant and thus 
only blocking the first dedicated step in the trichothecene pathway:  the 
cyclization of farnesyl pyrophosphate into trichodiene.   
A key gene in the regulation of the production of isoprenoid precursors 
available for terpenoid synthesis in Saccharomyces cerevisiae is Hmgr (42).  
Examination of Hmgr expression in the ∆Tri10 and ∆Tri6 strains revealed 
reduced transcript accumulation levels, with the lowest levels observed in the 
∆Tri6 strain (Fig. 4-2).  Hmgr transcript accumulation was not reduced in the tri5-
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1 strain, implying that the effects on Hmgr expression observed in the ∆Tri10 
and ∆Tri6 strains result from the disruption of Tri10 and Tri6 expression and not 
from a metabolite feedback loop responding to a potential change in FPP pools 
or T-2 toxin levels.  Furthermore, the transcript accumulation of Hmgr increased 
dramatically in the tri5-1/Gpd::Tri10 transformants compared to wild-type at all 
time points but not in the ∆Tri6 strain, which also displayed an increase in Tri10 
transcript levels.  Together, these data strongly argue that the expression of 
Tri10, through the activity of Tri6, is responsible for the enhanced Hmgr 
expression levels observed.   
 
In contrast to the results observed with Hmgr, the tri5-1 mutation, and 
thus the inability to make trichothecenes, did have an apparent effect on the 
expression of some of the trichothecene biosynthetic genes.  As seen in Fig. 4-
2, Tri1 Tri3, and Tri4 appear to accumulate slightly higher transcript levels in the 
tri5-1 strain compared to wild-type.  However, it is still possible that the point 
mutation alone may have produced a slight Tri10 overproduction phenotype.  
Additional experiments will be needed to determine if this effect is due to the 
alteration of the DNA sequences upstream of Tri10, the possible accumulation of 
FPP and/or its failure to enter into the trichothecene biosynthetic pathway, 
and/or the lack of T-2 toxin production or other pathway intermediates.   
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In addition, the tri5 and tri4 mutations had a marked effect on the 
transcript accumulation of Tri101, a trichothecene biosynthetic gene responsible 
for trichothecene C3-acetylation.  Tri101 exhibited a dramatic reduction in 
transcript abundance in both the tri5-1 strain (Fig. 4-2) and the tri4 strain (Fig. 4-
3).  These data imply that Tri101 transcript accumulation is enhanced by the 
presence of a trichothecene pathway metabolite beyond trichodiene.  However, 
this effect can be partially overcome by overexpressing Tri10 in a tri5 mutant 
background (Fig. 4-3). 
 
The regulation of isoprenoid biosynthesis is complex.  Another pathway 
which shares the same precursors (isoprenoid metabolites) as the trichothecene 
pathway is the ergosterol biosynthetic pathway.  Ergosterol is an essential 
component of fungal plasma membranes.  Regulation of ergosterol synthesis in 
S. cerevisiae hinges on the protein turnover rate of HMGR which has been 
shown to be controlled by FPP pools and a second unidentified compound 
believed to be an oxysterol (40, 41).  Additionally, transcription of Hmgr in yeast 
is regulated predominantly through a negative regulatory feedback loop in 
response to sterol.  In trichothecene biosynthesis, we have observed increased 
expression of the Hmgr gene coordinated with the expression of trichothecene 
genes (Chapter III).  This would be expected if, as in the yeast model, the sterol 
concentration in the cell were to drop in response to the increased utilization of 
FPP by the trichothecene pathway.  However, the present study showed that 
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expression of Tri10 by either the native Tri10 promoter or by the Gpd promoter 
was sufficient to increase Hmgr gene expression in the absence of the 
conversion of FPP to trichodiene.  Therefore, the expression of the 
trichothecene regulatory genes, Tri10 and Tri6, is directly tied to the regulation of 
Hmgr in F. sporotrichioides.  In Gibberella fujikuroi, the biosynthesis of another 
secondary metabolite, the gibberellins, also depends on the activity of HMGR.  
In this case, it was found that the addition of plant oil to the medium increased 
the expression of Hmgr, however the mechanism of the induction was unknown 
(109).  Curiously, a minimal TRI6 DNA binding sequence (YNAGGCC) is located 
in the promoter for the G. fujikuroi Hmgr gene.  As both F. sporotrichioides and 
G. fujikuroi are plant pathogens, it is possible that both pathogens share a 
similar signal transduction pathway to induce Hmgr expression.  The use of 
expanded cDNA microarrays coupled with the above mutants will be a powerful 
tool in identifying additional regulatory factors linking primary and secondary 
metabolism. 
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CHAPTER V 
 
CONCLUSION 
 
 The body of this work describes the continuing characterization of a novel 
regulatory gene, Tri10, from the trichothecene gene cluster and the discovery of 
an important regulatory link between primary and secondary metabolism in F. 
sporotrichioides mediated in part by the expression of Tri10.  The discovery of 
Tri10 (13) and its subsequent characterization and disruption (Chapter II) 
provided critical evidence that Tri10 was a positive regulator of Tri gene 
expression and allowed the development of a regulatory model for trichothecene 
production in F. sporotrichioides.  As depicted in the model shown in Fig. 5-1, 
the expression of Tri10 is required for wild-type expression levels of Tri6, a 
cluster-encoded transcription factor (87), and consequently the other cluster-
encoded and non cluster-encoded Tri genes. 
 
 Notably, Tri10 is the only Tri gene that does not depend at least in part on 
the expression of Tri6 to activate its transcription.  Conversely, Tri10 is 
negatively regulated by Tri6 expression since Tri10 transcript levels increase in 
the ∆Tri6 strain (Fig. 2-3).  This provides evidence for a regulatory loop between 
Tri10 and Tri6 which modulates the expression of the Tri genes. 
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 Tri10 increases Tri gene expression if it is overexpressed in either of two 
ways.  Both disruptions in the continuity of the region upstream from Tri10  
 
 
 
 
Tri5, Tri4 
Tri101 
Other Tri cluster
and 
non cluster 
Tri6 Tri10 
T-2 toxin 
Self Protection 
? 
? 
? 
?
Fpps
?
?Gα-
protein 
Hmgr 
Hmgs
Acat 
  FIG. 5-1.  Revised regulatory model for trichothecene production.  Solid arrows indicate 
known positive activities.  Dotted arrows indicate possible activation.  Blocked arrows 
indicate known inhibitory activities, and dotted blocked arrows indicate possible inhibitory 
activities.  Question marks indicate other hypothesized but unknown regulatory signals or 
factors.   
MAPK 
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and the expression of Tri10 under the control of the Gpd promoter whether 
located within or outside of the Tri gene cluster, also causes overexpression of 
Tri10, the Tri genes, and overproduction of T-2 toxin (Chapter III).  Thus, while 
the continuity of the Tri gene cluster upstream of Tri10 is required for wild-type 
Tri gene expression levels, the latter experiments demonstrated that neither the 
disruption of the Tri gene cluster nor the placement of the overexpression copy 
of Tri10 within the Tri gene cluster are essential requirements for the 
overexpression phenotype. 
 
During this study, it was discovered that the expression of Tri10 had an 
effect on the expression of one of the genes in the isoprenoid pathway; the 
primary metabolic pathway feeding into trichothecene synthesis.  The first 
isoprenoid gene which we cloned from F. sporotrichioides was Fpps and thus it 
was the first isoprenoid gene examined.  Fpps is responsible for the production 
of farnesyl pyrophosphate, the immediate precursor for the trichothecene 
pathway.  I examined the expression of Fpps in a strain in which Tri10 had been 
disrupted, a strain in which Tri10 was overexpressed, and a strain in which Tri6 
had been disrupted.  The disruption of either Tri10 or Tri6 led to a decrease in 
Fpps expression while the overexpression of Tri10 led to the overexpression of 
Fpps.  In addition, even though Tri10 was overexpressed in the ∆Tri6 strain, 
Fpps was not.  Thus both Tri10 and Tri6 are required for wild-type levels of Fpps 
expression and the increased transcript level of Tri10 alone is not sufficient to 
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increase Fpps expression.  Taken together, these results indicate that the 
positive expression of Fpps by Tri10 is mediated via Tri6.  These results also 
raised the following two questions.  First, were the remaining isoprenoid pathway 
genes regulated in a similar manner by Tri10 and Tri6?  Second, was the 
expression of Tri10 and Tri6 directly responsible for the observed increase in 
Fpps expression or was either the presumed change in the flow of farnesyl 
pyrophosphate into the trichothecene pathway or the lack of T-2 toxin production 
responsible for these changes?   
 
Insights into the first of the above two questions were provided by the 
following experiments.  In a differential cDNA macroarray screen for genes 
influenced by Tri10 expression, we discovered that the isoprenoid genes Acat, 
Hmgs, and Mk were positively regulated by Tri10.  Clones were isolated for 
these genes and used to generate probes for Northern blots which revealed that 
these genes were also positively regulated by Tri6 expression (A. W. Peplow, A. 
G. Tag, G. Garifullina, M. N. Beremand, in press).  The clones served as 
templates for the construction of targeted cDNA microarrays (Chapter III) which 
were subsequently probed with labeled cDNAs produced from ∆Tri10 and ↑Tri10 
strains and provided data that confirmed the results obtained from the 
Northerns.  Thus, the expression of Acat, Hmgs, and Mk, like that of Fpps, is 
also reduced in the ∆Tri10 strain and increased in the ↑Tri10 strain. 
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 In order to investigate whether Tri10 and Tri6 gene expression or either 
changes in the flow of FPP into the trichothecene pathway or the lack of T-2 
toxin production were responsible for changes in isoprenoid gene expression in 
the ∆Tri10 and ∆Tri6 strains, we chose to examine the expression of Hmgr, a 
gene which has been shown to function as a critical control point for isoprenoid 
synthesis in S. cerevisiae (40, 41), in the ∆Tri10, ∆Tri6, and two strains blocked 
very early in the trichothecene pathway.  The first of these two strains contained 
a nonsense mutation in Tri5 (tri5-1) that effectively blocked the first step of 
trichothecene synthesis, and hence, completely prevented the flow of farnesyl 
pyrophosphate into the trichothecene pathway.  The second strain was a tri4 
mutant which is blocked in the second step of the trichothecene pathway and 
therefore allows the flow of farnesyl pyrophosphate into the trichothecene 
pathway.  At the same time, all of these mutants share in common the failure to 
make any trichothecenes (Chapter IV).  Unlike the ∆Tri10 and ∆Tri6 strains, 
which showed a reduction in Hmgr expression, both the tri5-1 and tri4 strains 
exhibited wild type levels of Hmgr expression. These data indicate that neither 
the flow of FPP into the trichothecene pathway nor the production of 
trichothecenes is necessary for wild-type levels of Hmgr expression (Chapter 
IV).  Therefore, Hmgr expression is directly related to the expression of Tri10 
and Tri6. 
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Further evidence that Tri10 expression positively regulates Hmgr was 
provided by the analysis of tri5-1 transformants which carry a Tri10 
overexpression plasmid (pTri10-2) containing Tri10 under the control of the Gpd 
promoter (Chapter IV).  All of the tri5-1/Gpd::Tri10 transformants exhibited 
greatly increased Hmgr expression implying that overexpression of Tri10 was 
capable of upregulating Hmgr in the absence of trichothecene production.  
However, as was seen with the Tri genes, Tri10 mediates this control through 
Tri6 since the ∆Tri6 strain exhibits reduced Hmgr expression and increased 
Tri10 expression. 
 
 Unlike many of the other Tri genes, Tri101 resides outside of the 
trichothecene gene cluster (65).  During the first study concerning the effect of 
Tri10 gene expression on Tri gene expression, it became apparent that Tri101 
was under the control of additional regulatory controls which did not appear to 
respond like the other Tri genes (Chapter II).  For example, Tri101 is expressed 
at 15 h in the wild-type strain, at a time when the other Tri genes are not being 
expressed.  This was consistent with previous reports that Tri101 appeared to 
be “constitutively” expressed in F. graminearum when the Tri5 and Tri6 genes 
were not (65).  Therefore, although Tri10 and Tri6 play an important role in 
influencing the expression of Tri101, it clearly has other factors that regulate its 
expression (Chapter IV).  Additionally, Tri101 expression is reduced in both the 
tri5 and tri4 strains suggesting that the production of T-2 toxin or some pathway 
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intermediate(s) plays a role in increasing Tri101 expression.  In future studies, to 
determine if the effect is due to T-2 toxin or pathway intermediates, the tri5 strain 
could be grown in the presence of the individual trichothecene pathway 
intermediates from isotrichodermol, the substrate compound for TRI101, to T-2 
toxin and, by a process of elimination, the inducing compound should be 
determined.   
 
Tri10 also affects the expression of one or more genes involved in self 
protection, however not to the same extent as does Tri6 (Chapter II).  In two 
different assays, the ∆tri6 and ∆tri10 strains exhibited increased sensitivity to T-2 
toxin indicating that some of the self-protection genes and/or mechanisms are 
under the control of Tri10 and Tri6.  This control is apparently independent of the 
inability of the ∆Tri10 and ∆Tri6 strains to produce trichothecenes.  The 
trichothecene deficient tri4 stain exhibited wild-type levels of resistance to T-2 
toxin, demonstrating that producing trichothecenes is not a prerequisite for 
inducing self-protection mechanisms.   
 
 Since Tri10 is a key regulator for Tri gene expression and T-2 toxin 
production, understanding the factors which regulate Tri10 expression may 
provide novel methods to prevent trichothecene production. 
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Tri10 is both positively and negatively regulated by factors which are just 
beginning to be explored.  In filamentous fungi, G proteins have been shown to 
regulate secondary metabolism (47) and virulence (5, 68) through signal 
transduction pathways.  In a collaborative effort with Keller, et al., we found that 
a constitutively active allele of the alpha subunit of a heterotrimeric G protein, 
fadAG42R from Aspergillus nidulans, simultaneously delayed Tri gene expression, 
including Tri10 (data not shown), and resulted in increased toxin production in F. 
sporotrichioides (97).  This implicates G protein signal transduction pathways in 
the regulation of Tri gene expression and T-2 toxin production.  However, it is 
unclear how the G protein signaling pathway modulates Tri gene expression.  In 
A. nidulans, it has been shown that the regulation of sterigmatocystin production 
and conidiation by FadA is partially mediated through an adenylyl 
cyclase/cAMP/cAMP-dependant protein kinase (94).  To that end, a mitogen-
activated protein kinase (MGV1) has recently been isolated from F. 
graminearum and shown to be required for production of deoxynivalenol, 
colonization of the wheat head, and female fertility (55).  As MAP kinases 
frequently activate transcription factors, a homologue of MGV1 in F. 
sporotrichioides might be an intermediate transducer from a G protein to Tri10 
and Tri6 in the regulatory cascade that induces trichothecene production. 
 
The characterization of Tri10 has revealed little about its mechanism of 
action.  Database searches have not yielded any conserved functional motifs.  
 107
However, recently three fungal genomes have been publicly sequenced.  A 
search of these genomes has revealed that only one gene in each carries a 
gene which encodes a protein with some similarity to TRI10.  However, in each 
case this similarity is limited:  Aspergillus fumigatus (BLASTp score = 124, 
Evalue = 2 e-27), Neurospora crassa (PRO1a) (BLASTp score = 93, Evalue = 93 
e-17), and Magnaporthe grisea (BLASTp score = 79, Evalue = 3 e-13).  All three 
proteins potentially contain GAL4-type Zn(II)2Cys(6) binuclear cluster domains 
(a putative intron would need to be removed from the transcript to add this 
domain to the A. fumigatus protein) in their amino termini which would implicate 
them in regulatory processes.  The N. crassa PRO1a gene is the only one of the 
three to be characterized and it has been shown to be required for perithecial 
development (70).  In a typical member of the GAL4 family, the amino terminus 
of the protein contains the Zn(II)2Cys6 DNA binding domain and the carboxy 
terminus beyond the DNA-binding domain frequently contains a coiled-coil 
dimerization domain used in protein-protein interactions; commonly to form 
homodimers (101).  However, TRI10 does not contain a conserved Zn(II)2Cys6 
DNA binding domain and neither TRI10 nor any of the three similar proteins 
contain a conserved coiled-coil domain.  Furthermore, attempts to observe 
TRI10-TRI10 homodimers and TRI10-TRI6 heterodimers using the GAL4 yeast 
2-hybrid system did not indicate these interactions (data not shown).  A multiple 
alignment of TRI10 and the three similar proteins using ClustalW v1.4 (99) 
revealed that the majority of the conserved residues are nonpolar amino acids 
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and predominately leucine, although no conserved leucine septad repeats were 
observed which would indicate a leucine zipper (Fig. 5-2).  Experiments which 
would identify other proteins which interact with TRI10 may provide further 
understanding of its mechanism of action in the regulation of the Tri genes. 
Fusarium species cause devastating diseases of wheat, barley and maize and 
frequently contaminate the grain with mycotoxins making it unsuitable for food or 
feed purposes.  In the past decade, epidemics of Fusarium head blight of wheat 
have resulted in over 2.6 billion dollars in losses in the United States alone (77, 
108).  Efforts to control the disease have provided only moderate success since 
there are only a few sources of natural resistance available while the 
environmental conditions which favor the disease are common.  One potentially 
promising approach presently being pursued is to produce transgenic plants by 
incorporating genes for resistance mechanisms to the trichothecene toxins from 
other organisms, including the trichothecene-producing fungus itself, into plant 
lines with some naturally occurring resistance.  Currently under investigation are 
genes for an ABC transporter from yeast, a trichothecene 3-o-acetyltransferase 
(Tri101) (81), and a ribosomal protein variant (46).  These approaches are 
centered on countering the presence of toxin (not directly preventing its 
production) with the goal of providing additional resistance against the toxin to 
the host and/or as a means to effectively reduce the virulence of the pathogen.  
An extension of this tactic is the identification of additional fungal genes required  
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  FIG. 5-2.  Pairwise alignments of F. sporotrichioides TRI10 with similar proteins from 
Magnaporthe grisea (MG), Aspergillus fumigatus (Afum), and Neurospora crassa PRO1a 
(NC).  Shaded areas indicate conservation.  Dots indicate conservative substitutions.  
Dashes indicate gaps. 
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for toxin production that could be candidate genes for producing resistant 
transgenic plants. 
 
This research has contributed to the overall understanding of 
trichothecene gene regulation and has brought to light a novel regulatory link 
  FIG. 5-2. Continued 
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between secondary and primary metabolism in fungi.  Strains and information 
provided by this work have also be instrumental in the identification of additional 
genes under the control of Tri10 (A. W. Peplow, A. G. Tag, G. Garifullina, and M. 
N. Beremand, in press) including additional genes required for T-2 toxin 
production (78).  However, more work is needed to identify those components of 
the regulatory circuitry that are responsible for turning Tri10 and Tri6 on and off.  
A better understanding of the genetic and environmental factors contributing to 
the production of trichothecenes may give rise to additional novel strategies to 
prevent Fusarium mycotoxin production in crops. 
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APPENDIX A 
 
Supplementary Table 1.  
 
Array Identifier wt/∆Tri10  23h wt23vswt 48h wt23vswt 60h wt23vs#24 23h wt23vs#24 48h wt23vs#24 60h
 
Tri6 1.285 1.360 0.947 1.604 4.141 2.671
Tri4 0.285 0.893 1.748 1.232 2.236 1.341
Tri11 0.135 0.713 0.428 1.964 6.542 1.669
Tri13 0.043 0.754 0.641 1.533 7.789 2.781
Tri1 0.033 0.488 0.356 1.353 2.378 1.683
Tri10 1.826 2.236 2.858 4.901 18.942 15.089
Tri3 0.091 0.808 0.409 2.774 14.233 1.928
Tri7 0.200 0.855 0.538 3.219 9.786 3.036
Tri8 1.003 0.512 0.933 1.277 2.249 1.118
Tri101 0.161 0.396 0.851 1.262 1.650 0.823
Tri15 0.213 0.860 0.959 1.383 0.898 0.89
Tri5 0.836 1.308 1.622 1.313 2.369 0.687
Tri9 0.302 1.325 1.749 1.983 6.761 0.693
Tri12 0.117 1.951 1.310 6.367 24.129 8.554
Tri14 0.046 1.376 0.859 1.603 2.334 1.875
Pyruvate kinase 1.838 2.064 2.057 2.770 2.754  
Dhat 1.400 1.502 1.857  
Acat 0.485 1.635 0.826 2.162 4.452 3.552
Hmgs 0.192 1.592 0.803 4.757 25.718 6.463
Mk 0.452 1.337 7.735 2.166 4.188 2.234
Pmk 1.275 1.508 2.079 3.551
Fpps 0.247 0.745 0.379 1.946 4.329 0.889
Citrate synthase 1.097 1.440 1.816 0.991 2.521 0.909
Aconitate hydratase 0.752 2.133 1.199 0.771 1.408 0.559
Isocitrate dehydrogenase 1.768 1.832 2.609 5.438 6.034 2.169
rAsp f9 1.036 1.566 1.744 0.883 2.257 0.738
Ibt4 0.416 2.458 2.325 0.995 6.887 3.06
Ibt6 0.599 1.032 0.665 0.944 3.517 1.153
Ibs1 0.973 0.122 0.439 0.438 0.549 0.164
Ibt1 0.441 2.318 2.082 1.116 10.406 5.246
ADP/ATP Carrier protein 1.049 1.239 1.590 1.654 1.467 0.717
Potassium Channel protei 0.984 2.326 4.579 2.138 14.793 6.066
RNase F1/T1 0.997 0.738 1.772 1.262 0.266 0.033
Alcohol dehydrogenase 0.979 1.035 0.743 1.022 0.535 0.652
Transcription factor 1.002 1.841 1.757 1.194 2.234 0.702
18I12 1.134 2.281 2.286 3.806 4.023 1.172
15G19 1.334 1.738 1.788 1.334 3.137 1.306
9D4 0.630 3.992 2.07
17H21 0.940 1.758 1.757 1.250 2.482 1.531
12M24 0.906 1.288 1.440 2.607 1.304 1.202
11K18 1.355 2.542 8.362 1.234
Cell wall protein 1.003 0.784 1.592 0.345 0.740 0.388
ABC Transporter 0.992 1.788 2.934  
Histone H2A subunit 1.192 0.714 1.490 0.768 0.794 0.302
Nucleosome assembly 0.974 1.360 1.741 2.250 3.553 1.053
Stress protein 0.996 0.565 1.789 1.278 1.639 0.705
Elongation factor 1 alpha 1.000 1.262 1.988 2.170 2.687 1.918
Elongation factor 2 1.001 1.483 1.431 1.527 1.526 1.029
RNA pol II large subunit 1.001 1.183 2.840 1.817 2.178 2.483
Core II protein 1.057 0.714 0.633 1.133 0.789 0.852
Actin 1.000 1.000 1.000 1.000 1.000 1
Cytochrome P450 1.001 1.086 0.630 0.856 0.382 0.429
fadA 1.000 0.572 0.974 1.523 0.875 0.74
Values shown are Cy5/Cy3 ratios which have been normalized to actin.
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Supplementary Table 1.
Array Identifier wt23vs#49 23h wt23vs#49 48h wt23vs#49 60h wtvs↑Tri10  23h wt23vs↑Tri10 48h
Tri6 3.803 4.08 2.346 1.268
Tri4 1.399 1.45 1.554 0.962 2.68
Tri11 3.364 2.484 3.256 2.428 2.128
Tri13 2.397 1.832 2.347 1.387 1.907
Tri1 1.344 1.212 1.555 1.332 1.807
Tri10 2.051 10.842 18.226 5.391 2.794
Tri3 4.113 4.587 4.919 1.246 1.988
Tri7 2.493 3.293 4.914 2.263 2.14
Tri8 0.896 1.089 1.538 0.963 1.469
Tri101 0.82 1.252 1.562 0.963 1.851
Tri15 2.283 1.26 1.079 1.207 2.128
Tri5 0.962 1.097 1.543 0.954 2.683
Tri9 2.566 1.052 1.801 0.962 2.684
Tri12 5.227 9.15 13.824 3.357 2.022
Tri14 2.712 1.595 1.85 1.023 2.139
Pyruvate kinase 3.589 5.069 5.644 1.718 2.216
Dhat 2.552 2.519 1.963
Acat 2.251 2.627 4.778 1.458 1.715
Hmgs 6.308 6.586 11.714 2.684 3.416
Mk 7.689 4.683 3.366 3.683 3.06
Pmk 9.178 1.384 3.131
Fpps 2.651 1.635 1.864 1.834 1.9
Citrate synthase 1.124 0.917 1.452 2.492 1.749
Aconitate hydratase 1.278 0.725 1.104 1.121
Isocitrate dehydrogenase 13.48 9.395 6.153 1.406 3.062
rAsp f9 1.1 1.043 1.643 0.966 1.948
Ibt4 1.597 2.127 6.133 2.804 1.51
Ibt6 1.425 1.13 1.509 1.536 1.801
Ibs1 0.817 0.616 0.276 0.963 9.805
Ibt1 1.808 3.956 4.214 2.58 1.321
ADP/ATP Carrier protein 1.642 1.067 2.006 0.96 0.855
Potassium Channel protei 2.44 7.361 9.704 0.48 2.063
RNase F1/T1 1.017 0.403 0.531 0.963 0.56
Alcohol dehydrogenase 1.786 1.114 1.449 2.667
Transcription factor 0.829 1.036 1.579 0.964 1.831
18I12 1.204 1.448 3.446 1.006 1.367
15G19 0.97 1.094 2.256 0.961 0.977
9D4 6.907 1.432 2.687
17H21 0.824 1.448 2.318 1.189 0.719
12M24 5.052 2.342 1.461 1.333
11K18 5.67 6.103 1.681 3.654
Cell wall protein 0.643 0.666 0.954 0.961 1.4
ABC Transporter 10.948 6.172 0.836 1.708
Histone H2A subunit 0.838 0.291 0.659 0.928 0.705
Nucleosome assembly 1.996 1.394 3.279 1.203 1.039
Stress protein 0.768 1.036 1.565 0.906 1.112
Elongation factor 1 alpha 0.886 0.994 2.053 1.014 0.89
Elongation factor 2 2.142 1.065 1.579 0.964 1.241
RNA pol II large subunit 1.715 0.89 3.431 0.984 1.06
Core II protein 1.372 0.628 0.931 1.574 1.204
Actin 1 1 1 1 1
Cytochrome P450 1.356 0.561 0.555 0.964 0.858
fadA 3.757 1.575 1.684 1.318 1.134
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